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"Nothing in biology makes sense except in the light of evolution" 
Theodosius Dobzhansky 
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ABSTRACT 
When genome integrity is perturbed, surveillance and repair mechanisms are activated to 
restore genome integrity through high fidelity DNA repair. However, in some physiological 
situations, those mechanisms are channeled away from integrity towards mutations and 
recombinations. During the diversification of the immunoglobulin locus in B cells, 
Activation Induced Deaminase (AID) triggers the physiological introduction of mutations.  
The current work was based on the observation that upon simple lesion generation, AID-
induced deamination of a cytosine to uracil, the resolution by the molecular mechanism of 
DNA repair can lead to different outcomes. This homeostatic outcome, error-free or error-
prone, is governed by specific cellular context and processes associated with DNA. To 
uncover the regulation of the pathway choice an in vitro system, named in vitro resolution 
(IVR), was developed. In the 1st phase of the IVR, AID was targeted to a DNA plasmid for 
uracil lesion generation. In the 2nd phase, a cellular extract resolved the lesions via Base 
Excision Repair [BER, divided in short patch (SP)-BER or long patch (LP)-BER] or 
Mismatch Repair (MMR). The quantitative nature of the IVR provided a novel means to 
precisely quantitate the contribution of each single DNA repair pathway. This set-up 
allowed us to evaluate how different cellular environments influenced the choice. Cell 
origins presented quantitative differences in DNA repair kinetics: a) overall sensitivity, b) 
non-B cells activating non-canonical MMR first, c) B cells activating SP-BER first, and d) 
LP-BER is significantly activated only in B cells. To understand the possible molecular 
mechanisms, we analysed single components known to influence DNA repair, such as 
transcription, protein availability, and chromatin. Changing the DNA substrate to either 
prefer or avoid forming nucleosomes, we uncovered significant changes in AID 
deamination preference and in DNA repair pathway choice. DNA with nucleosome 
favourable base-stacking preferred LP-BER, while non-nucleosome stacked DNA 
preferred SP-BER and MMR. Overall our findings provide novel insight into the cellular 
context that can influence DNA repair. The use of B cells and cancer cell lines can 
recapitulate in vivo Ig locus diversification, and our findings have a direct bearing in 
understanding mechanisms of tumorigenesis. 
INTRODUCTION 
CHAPTER 1 - INTRODUCTION 
 
1.1 - GENOME STABILITY PERTURBATION AND SURVEILLANCE MECHANISMS  
 
DNA is a fragile molecule and its stability depends on fine interactions between bases, 
such as base pairing between complementary strands and base-stacking interactions 
between adjacent bases. Already in 1953 Watson and Crick proposed that adenine and 
thymine (dA and dT) are held together by two hydrogen bonds, while guanine and cytosine 
(dG and dC) are involved in three hydrogen bonding. These bonding are necessary to hold 
the two strands of DNA together. The spacing between parallel base pairs is stabilized by 
base-stacking forces: adjacent base pairs attract one another through non-covalent forces, 
while due to the hydrophobic interactions the polar surfaces of the bases are exposed to 
the surrounding environment.  
In mammalian cells the very long linear DNA molecule is compacted for protection and 
regulation when it is associated with proteins – forming the nucleosome: 147 base pairs 
are wrapped around eight histone molecules, forming the basic repeat unit of chromatin. 
Various interconnected mechanisms regulate DNA accessibility, stability and dynamics, 
with slight variations in the chemistry of the DNA bases having profound implications on 
the stability of the DNA duplex. 
 
1.1.1 - DNA spontaneous instability 
Although DNA carries the genetic information, it can be considered fragile because it is 
chemically instable and susceptible to damage. Modifications such as hydrolysis, oxidation 
and alkylation occur at significant rates in vivo, increasing DNA instability (1) (Table1).  
DNA has N-glycosyl bonds susceptible to spontaneous hydrolysis. In particular purines are 
lost more rapidly than pyrimidines (2). Moreover, in single-stranded DNA (ssDNA) cytosine 
residues are susceptible to hydrolytic deamination, which lead to conversion into uracil 
(dU). The double helix structure, through specific hydrogen bonding patterns, provides a 
good protection against this spontaneous reaction (3). 	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Another chemical feature of DNA that contributes to its instability is the presence of 
oxygen and nitrogen atoms in its bases, which can be targets of reactive oxygen species 
(ROS), which are produced during normal cellular metabolism. The major base lesion 
generated by ROS oxidation is 8-hydroxiguanine (8-oxo-G), which can base-pair with 
adenine rather than cytosine. Other reactive molecules can modify the double helix 
structure, one of them is S-adenosylmethione, which can mediate alkylation of guanine 
and adenine (4).  
 
Spontaneous damages occurring every day in 
the genome of a cell  
20000 ssDNA breaks 
10000 depurinations 
5000 alkylating lesions 
2000 oxidative lesions 
600 deaminations 
50 sister chromatid cross 
 
Table1 - Spontaneous DNA damages occurring every day  
 
Other cellular processes like lipids peroxidation and cellular stress have a role in 
increasing the amount of modified DNA bases (5). The replication process itself can be a 
source of DNA instability, if a nucleotide with an incorrect base is incorporated in the 
nascent strand. Misincorporations occur every 106 to 108 nucleotides for replicative 
polymerases (6). DNA instability can also result from insertion or excision of (retro-) 
transposons. Furthermore, specific regions in the genome, hotspots, have a higher 
probability to host instability, because of their sequence composition: including DNA 
repeats, fragile sites, slow replication zones, G-quadruplexes and telomeres. For example, 
tandem repeats undergo long expansions during replication, due to their particular 
sequence composition (7), and fragile sites can be composed of several AT-rich repeats 
susceptible of breakage (8).  
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1.1.2 - DNA environmental instability  
Besides endogenous instability, environmental agents, such as chemical or physical 
agents and microorganisms (MO), can induce specific adverse effects on genome stability. 
Ultraviolet (UV)-B radiation induces abundant mutagenic and cytotoxic DNA lesions, such 
as cyclobutane–pyrimidine dimers (CPDs) and 6–4 photoproducts (6–4PPs) (9) at 
dipyrimidine sites, where two pyrimidine bases are juxtaposed in the nucleotide sequence 
of DNA. Each CPD impairs DNA polymerases progression during replication. Furthermore, 
UV-A can cause DNA damage indirectly through the production of ROS. 
Several DNA aberrations, such as base damages, single strand breaks (SSBs) and double 
strand breaks (DSBs) can be observed after exposure to ionizing radiations (10). X-rays 
can ultimately lead to dramatic genetic changes such as deletions, translocations and 
other chromosomal rearrangements. 
Chemical mutagens are classified into different groups based on the mechanism by which 
they interact with DNA (11). For example, base analogues are chemicals that structurally 
resemble normal DNA bases, but often pair with the wrong bases, leading to base pair 
changes in the DNA. Frameshift mutagens can intercalate between bases in the same 
strand of the DNA, increasing the distance between the bases and producing helix 
distortions. Other chemicals can directly modify bases or bind covalently to DNA with 
subsequent addition of some organic group to the bases or to the sugar–phosphate 
backbone.  
Exogenous DNA damaging agents can be found in toxic tobacco residues, air pollution, 
pesticides, toxic metals and food toxins. Toyooka et al. demonstrated that cigarette 
sidestream smoke can induce DSBs (12). While many other compounds were proven to 
induce DNA damage directly or indirectly through ROS generation: asbestos, silica, and 
titanium dioxide (13). Calderón-Garcidueñas et al. were able to detect ROS-induced SSBs 
in single cells of the nasal epithelium of patients exposed to air pollutants (14). 
MO infection can also be an important source of DNA damage. Helicobacter pylori, 
through adhesion molecules, directly induces DSBs in infected cells in a time- and dose-
dependent manner (15).  
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Similar, viruses can damage DNA: the human papillomavirus (HPV) E7 protein is able to 
inactivate pRB, leading to the accumulation of DSBs, and as a consequence genomic 
rearrangements, chromosomal abnormalities, DNA repair errors, and aneuploidy (16). The 
same molecular DNA damaging mechanism was demonstrated for human 
immunodeficiency virus type 1 (HIV-1) (17).  
As a result of exposition of DNA to spontaneous and induced damages, every day each of 
our cells accumulates thousand of lesions. It is then important to distinguish between DNA 
damage, a physical abnormality in the DNA, and mutation, which is a change in the base 
sequence of the DNA. Not all DNA damages are converted into mutations. To ensure an 
accurate transmission of genetic information, cells have evolved a complex system of 
surveillance and DNA repair mechanisms, which prevent damaged DNA from being 
converted into inheritable mutations.  
 
1.1.3 - DNA damage response 
DNA damage-response (DDR) includes a set of DNA repair mechanisms, damage 
tolerance processes, and cell-cycle checkpoint pathways. To allow complete lesion 
resolution prior to replication or cell division, DDR is linked to an intricate signal 
transduction cascade that induces cell cycle arrest, hence providing time for DNA repair 
(18,19). Different types of DNA damages can activate different DDR signalling cascades. 
DDR is a multistep process composed of proteins that sense the damage and kinases, 
such as ataxia-telangiectasiamutated (ATM) (20) and ataxia-telangiectasia and Rad3-
related (ATR), that activate effector proteins. For an efficient checkpoint response ATM 
and ATR kinases phosphorylate a large number of targets that participate in DNA repair, 
checkpoint signalling, and determine cell fate decision, such as apoptosis or senescence 
(21). Checkpoint kinase 1 and 2 (CHK1 and CHK2) coordinate the inhibition of cell cycle 
progression, ensuring the DNA repair machinery enough time to perform efficient repair 
before replication. Alternatively, when too many DNA injuries are encountered, apoptosis 
can be triggered by p53 to protect the organism from potential tumorigenic transformations 
(22). Another DDR kinase is DNA-dependent protein kinase (DNA-PK), which is also 
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activated by irradiation-induced DSBs and is essential for repair activation or induction of 
apoptosis (23,24). 
DDR kinases control DNA repair at different levels. In particular, they can directly regulate 
DNA repair enzymes through post-translational modifications (PTM) or modify the 
chromatin near the lesion, creating the permissive local environment needed for repair 
(25).  
Repair of the DSB, either by homologous recombination (HR) and non-homologous end 
joining (NHEJ) (discussed in chapter 1.2.4), signals the return of the cell to homeostasis 
(26): DNA repair proteins and chromatin modellers are removed from the DDR site and the 
checkpoint response is inactivated.  
 
1.2 - DNA REPAIR MECHANISMS 
 
The functional DDR response can be activated upon lesions that require cell cycle 
coordination for repair, but when DNA lesions can be rapidly cleared, single repair 
mechanisms are independently activated. Various DNA alterations (discussed in chapter 
1.1) require detection by specific recognition proteins.  
In general, although cross-talk exists, each repair mechanism is activated by a particular 
set of DNA damage (Figure 1). Principal repair mechanisms are: base excision repair 
(BER), mismatch repair (MMR), nucleotide excision repair (NER), HR and NHEJ. 
Furthermore, persisting lesions can still be processed to avoid stalled DNA polymerases 
via DNA damage tolerance mechanisms.  
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Figure 1 - DNA damage and DNA repair specificity  
Endogenous (replication errors and spontaneous reactions) and environmental (ROS, X-rays, UV) 
DNA damage can result in: modified bases (oxidation or uracil), base pair mismatches, bulky 
adducts, SSBs and DSBs. Upon sensing DNA damage the cells activate the DNA repair 
machinery. Each type of lesion is repaired by biochemically distinct and highly specialized repair 
pathways, such as BER, MMR, NER and DSBR. DNA repair pathways can act independently or 
co-ordinate to repair DNA lesions. 
 
 
1.2.1 - Base Excision Repair 
BER is highly conserved from bacteria to humans and is active against the vast majority of 
endogenous DNA damages, including alkylations, oxidations, deaminations, depurinations 
and SSBs (Figure 1). The initial step in BER is the search and excision of a lesion along 
DNA molecules and it is carried out by DNA glycosylases. Currently, 11 mammalian 
glycosylases have been characterized and they differ from one to another with regard to 
substrate specificity (27).  Glycosylases and their substrate specificities are summarized in 
Table 2. 
 
 
© Dexheimer, T.S. (2013)
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DNA 
glycosylase 
Major Substrate 
UNG uracil (dU) 
SMUG1 dU, 5-hydroxymethyluracil 
TGD thymine (dT), dU, ethenocytosine 
MBD4 dT and dU opposite guanine (dG), dT opposite O6-methyl-
guanine 
MUTYH adenine (dA) opposite 8-oxo-G, 2-hydroxyadenine opposite dG 
OGG1 8-oxo-G opposite dC, formamidopyrimidine dG 
NTHL1 thymine glycol, formamidopyrimidine dG, Dihydrouracil, 5-
hydroxyuracil, 5-hydroxycytosine 
NEIL1 as NTH1 and formamidopyrimidine dA, 8-oxo-G 
NEIL2 overlap with NTH1/NEIL1 
NEIL3 unknown 
MPG 3-methyladenine, hypoxanthine, ethenoadenine 
 
Table 2 - Mammalian DNA glycosylases substrate specificities 
Modified bases or base adducts that are recognized by specific DNA glycosylases.  
 
DNA glycosylases can be either monofunctional, if they catalyze only the hydrolytic 
removal of the base to form an apurinic/apyrimidinic (AP) site or bifunctional if they can 
also cleave the DNA 3’ to the base that has been removed (28,29). The first step of 
processing of the AP site was discovered by Lindhal in 1974: the DNA incision is made by 
AP endonuclease 1 (APE1), which leaves a sugar attached to the 5’ of the nick ((5'-
deoxyribose phosphate (dRP)). The resulting 3’ hydroxyl is a substrate for DNA 
polymerase β (Pol β), which has also a lyase activity to remove the dRP. Once Pol β filled 
the single gap with its DNA synthesis activity, DNA ligase 3α (Lig3α), with the cofactor 
scaffolding protein X-ray repair cross-complementing protein 1 (XRCC1), can seal the nick 
(30). This pathway is called short-patch BER (SP-BER) (Figure 2).  
An alternative mechanism was described by Dogliotti et al. and is termed long-patch BER 
(LP-BER) (31). LP-BER is activated upon oxidation/reduction of sugar bases, when Pol β 
cannot remove the dRP (32), thus removal and replacement of 2-10 bp is needed. Other 
studies suggest that the switch between SP-BER and LP-BER is modulated by the ATP 
concentration near the AP site (33). In LP-BER the DNA polymerases δ and ε (Pol δ/ε) in 
combination with proliferating cell nuclear antigen (PCNA) and replication factor C (RF-C) 
can displace the strand 3’ to the nick and synthetize up to 10 nucleotides. Flap 
endonuclease 1 (FEN1) cuts the displaced strand and finally ligation is mediated by DNA 
ligase 1(Lig1)(31) (Figure 2). 
INTRODUCTION 
	   	  	  	   21 
                        
 
Figure 2 - Schematic illustration of BER subpathways  
BER is normally initiated by DNA glycosylases, which specifically recognize and excise the 
damaged base. BER is composed of two sub-pathways: short-patch BER (top), where only one 
nucleotide is replaced thanks to the activity of APE1, Pol β and Lig3 and long-patch BER (bottom), 
where 2-13 nucleotides are replaced. In LP-BER Pol δ/ε are kept on place by PCNA, which 
promotes the synthesis of several bases (represented as a blue line), while the original bases are 
cleaved off by FEN1. 
 
Alternatively, SSBs can be repaired by a specialized BER mechanism, named single-
strand break repair (SSBR). Poly (ADP-ribose) polymerase 1 and 2 (PARP-1 and PARP-2) 
are activated upon SSB and synthetize chains of poly (ADP-ribose) on to proteins, 
including auto-polymersiation. This leads to the recruitment of XRCC1 and Lig3α, where 
they form a molecular scaffold for subsequent recruitment of DNA polynucleotide kinase 
(PNK), APE1 and Pol β (34). Damaged 5’ or 3’ termini are converted by APE1 or PNK, 
which possess both 5’ DNA kinase and 3’ DNA phosphatase activities that generate 5’ 
phosphate and 3’ hydroxyl DNA ends for DNA synthesis. Pol β enables single nucleotide 
gap filling, followed by ligation by Lig3α. PARP-1 has been shown to stably interact with 
specific DNA glycosylases (35,36) suggesting possible intercommunication between 
different BER steps and pathways.  
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1.2.2 - Mismatch Repair 
 
1.2.2.1 - Canonical Mismatch Repair 
MMR corrects DNA oxidation damages as well as mismatches, insertions, and deletions 
generated during DNA replication (Figure 1). Inactivation of MMR proteins in human cells 
lead to an increase in the number of spontaneous mutations and is associated with human 
cancers (37). MMR is highly conserved with orthologous pathways between humans and 
E. coli (38). MMR pathway can be divided into three steps: 1) recognition, 2) excision, 
where the region surrounding the mismatch is removed, and 3) repair synthesis, where the 
gap is filled by the DNA polymerases (Figure 3A).  
The mismatch recognition proteins are the ATPases hMutSα and hMutSβ, composed of 
MSH2 forming heterodimers with MSH6 or MSH3, respectively (39). 80 – 90 % of the 
cellular MSH2 is complexed as hMutSα, which preferentially recognizes base-base 
mismatches, while hMutSβ preferentially recognizes larger mispairs (small insertion or 
deletion). The mismatch-recognition proteins recruit MLH1, which in turn can form a 
heterodimer with PMS2, PMS1, or MLH3 (39). hMutLα, which is composed of MLH1 and 
PMS2, accounts for 90 % of the MLH1 in human cells (40), and is necessary to activate 
exonuclease mediated degradation of the damaged strand.  
This degradation is performed by exonuclease 1 (EXO1) through its 5’ to 3’ exonuclease 
activity (41). Degradation is initiated by either a 5’ encision, which is directly preformed by 
EXO1 in the presence of hMutSα and RPA, or by a 3’ nicking, requiring PCNA and RFC to 
activate hMutLα endonuclease activity (42). PCNA interacts with hMutLα via a conserved 
PCNA motif, termed PIP box (43). EXO1 induced resection from the nick to the lesion can 
extend for up to 2000 bases. 
 
INTRODUCTION 
	   	  	  	   23 
 
Figure 3 – Schematic representation of MMR variants 
A) Base mismatch replication errors are recognized by the MSH2–MSH6 heterodimer, which 
recruits the MLH1–PMS2 heterodimer to initiate EXO1-mediated degradation of the damaged 
strand. Non-ubiquitinated PCNA mediates high-fidelity resynthesis recruiting DNA Pol δ. B) During 
somatic hypermutation (SHM) in B cells, PCNA is mono-ubiquitinated at lysine 164 and recruits 
DNA Pol η, which mediate and an error-prone DNA resynthesis, leading to introduction of 
mutations. C) The same mutagenic pathway has been observed in non-B cells. 
 
Recently, a structural function for EXO1 as been identified, where cells without EXO1 
nuclease activity are MMR proficient, in part because the mutant EXO1 is still able to 
interact with other MMR proteins and coordinate repair (44). As in BER, RPA protects the 
© Adapted from Hsieh P. (2012) Mol. Cell
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ssDNA-gapped region generated during excision. DNA re-synthesis is then catalysed by 
DNA Pol δ/ε and lastly completed by Lig1 action. 
 
1.2.2.2 - Non Canonical Mismatch Repair 
Non-canonical MMR (ncMMR) was described in B cells as a variant of mismatch repair 
and it is activated by a variety of lesions. ncMMR differs from canonical MMR in its 
mutagenic outcome. During B cell development, mutations are introduced in the Ig locus 
(discussed in chapter 1.4.2.2): error-prone MMR generates antibody diversity in B cells 
during the Somatic Hypermutation (SHM) process  (Figure 3B). Key roles for MSH2, 
MSH6, as well as EXO1 have been identified, but ablation of MSH3, MLH1, or PMS2 has 
only minor effects on the process (45-47). Interestingly, during SHM only 20–30 bp are 
excided (48). Presumably, recruitment of MSH2 and MSH6 has a role in determining the 
EXO1 (or some as yet unknown nucleases) excision process (49). 
In canonical MMR, a non-ubiquitinated PCNA mediates high-fidelity resynthesis recruiting 
DNA Pol δ. In SHM and in ncMMR, PCNA is recruited by MutSα / MutLα and is mono-
ubiquitinated at lysine 164 (K164) (50,51). This modification induces the recruitment of 
DNA polymerase η (Pol η), a translesion polymerase that mediates an error-prone DNA 
synthesis, leading to the incorporation of incorrect nucleotides (49,50). In particular, during 
SHM MMR is responsible for 80–90 % of dA:dT mutations. Mice with mutation in PCNA 
K164 don’t display A:T mutations in B cells, because they fail to recruit and activate the 
error-prone Pol η (52). 
Importantly, Peña-Diaz et al. used an in vitro system to monitor repair of dG:dU 
mismatches and identified the ncMMR pathway exists also in HEK293T cells, a human 
embryonic kidney-derived cell line, and is activated by non-immune stimuli (53) (Figure 
3C). This suggested a more physiological role for ncMMR. 
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1.2.3 – Other repair pathways 
Aside from BER and MMR, other DNA repair pathways can recognize specific DNA 
lesions or process intermediates of BER and MMR. They include Nucleotide Excision 
Repair (NER), DSB repair and DNA damage tolerance. 
NER is the preferred pathway for removal of bulky DNA lesions formed after exposure to 
radiation or chemicals (Figure 1). Several human genetic disorders, including Xeroderma 
pigmentosum (XP), Cockayne syndrome (CS), and Trichothiodystrophy (TTD), are 
associated with specific NER protein deficiency, underlying the crucial role of those 
molecules in human physiology. Two sub-pathways of NER are characterized: 1) the 
transcription coupled repair (TCR), selective for lesions present in the transcribed strand 
genes (54), and 2) the global genome NER (GGR) that recognize lesions distributed over 
the rest of the genome. 
DSBs can be generated both by exogenous sources, such as ionizing radiation, as well as 
via endogenous sources. Endogenous DBSs can arise either spontaneously, for example 
when DNA replication forks encounter unrepaired DNA lesions, which results in fork 
collapse (55), or DSBs can be programmed, for example during chromosome segregation 
(56) or Ig diversification (57) (discussed in chapter 1.4.2). DSBs are repaired by NHEJ or 
HR, two pathways which differ in the synthesis fidelity and in the template requirements.  
NHEJ mediates the re-ligation of the broken DNA molecule and does not require a 
homologous template; therefore it is not restricted to a certain phase of the cell cycle. 
NHEJ sequential steps are: 1) DNA ends recognition and assembly of the NHEJ complex, 
2) protection of DNA ends from non-specific processing, 3) DNA end processing, and 4) 
ligation of the broken ends. Ligation of the DSB ends promoted by NHEJ is then frequently 
error-prone, with small insertions, deletions and substitutions at the break site (58).  
In contrast to NHEJ, HR is largely error free and is more prevalent after DNA replication, 
when an identical sister chromatid is available as template for homologous repair (59). The 
HR reaction includes the following sequential steps: 1) resection of DNA ends, 2) 
homologous DNA pairing, 3) strand invasion, 4) DNA synthesis and 5) processing of HR 
intermediates. The HR process (reviewed in (60)) begins with the resection of DSBs to 
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generate 3′ ssDNA overhangs. This ssDNA is coated by RPA, which is subsequently 
replaced by Rad51 recombinase to mediate homologous DNA pairing (61). Rad51 triggers 
the formation of a connection between the invading DNA and the homologous template, 
until DNA molecules become aligned, producing a joint molecule. Other mediator proteins 
such as BLM, Rad54, Rad51AP1 and BRCA2 are also involved in this recombination 
process. DNA is synthesized using the invading 3’-end as a primer, forming a Holliday 
junction. Resolution of the structure can generate crossover or non-crossover products 
(discussed in chapter 1.4.2.1) (60).  
DNA damage tolerance (DDT) mechanisms do not remove lesions, but are temporary 
solutions to overcame stalled DNA replication. It is carried out by a set of either error-
prone or error-free processes. Translesion synthesis (TLS) allows the replication 
machinery to bypass DNA lesions using a low-fidelity DNA polymerase (62). TLS 
polymerases such as Pol η, Pol κ, Pol ι and Rev1 belong to the Y-family polymerases. 
These polymerases can synthesise directly across DNA lesions, but lack the proofreading 
activity, are non-processive, and contain active sites that can accommodate aberrant 
bases and base pair mismatches (63). The process of TLS requires the exchange of the 
replicative polymerase with TLS polymerases. TLS patch is then extended from 5 to 60 
nucleotides, depending on the lesion and polymerase involved (64).  Ultimately, a second 
switch brings the replicative polymerase to the DNA template and processive DNA 
replication is restored (65). 
Another DDT mechanism is called template switching, as it is carried out replacing the 
DNA containing the damage with the intact template strand of the sister chromatid, and as 
such this process is error-free (66). The key regulatory mechanism controlling DNA 
damage tolerance is post-translational modification of PCNA. DNA damage induced 
monoubiquitination of K164 by RAD6-RAD18 induces the switch from the replicative to a 
TLS polymerase (67,68). Polyubiquitination of K63 in PCNA instead promotes template 
switching (69). 
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1.2.4 - Crosstalk between DNA repair pathways  
 
Crosstalk among repair pathways plays an important role in regulating how DNA lesions 
are repaired. As a consequence of evolution, some of the DNA repair mechanisms have 
overlapping specificities, giving rise to the need to coordinate their activities, and the 
interaction between two or more repair pathways can lead to competition or cooperation. 
Competition is more likely to appear at the first stages of repair, since different repair 
proteins can recognize the same lesion. A deaminated 5-methyl cytosine base paired with 
guanine (a dT:dG mismatch) can be recognized by both a specific glycosylases in BER 
and by MutS ATPases in MMR. hMYH, an adenine DNA glycosylase responsible for the 
removal of the lesion 8-oxoG via LP-BER, can interact with hMSH6 in the hMSH2/hMSH6 
heterodimer (70). While methyl-CpG binding domain protein 4 (MBD4), a DNA glycosylase 
that recognizes dT:dGand dG:dU mismatches was reported to interact with the MMR 
protein MLH1(71). It is then necessary to ensure that the most appropriate response is 
activated in order to repair the lesion and to reduce replication errors that may occur 
during the repair processes. Solutions to the competition may be related to a cell cycle 
regulation of the amount of proteins expressed, PTM and degradation, which may favour 
one repair pathway over others (discussed in chapter 1.6).  
Interactions between different pathways are not necessarily competitive, they can also be 
cooperative: uracil DNA glycosylase (UNG) and hMutS are reported to cooperatively 
generate Ig locus diversification (45) (discussed in chapter 1.4.2.2). Cooperation may be a 
consequence of a direct protein-protein interaction or may be mediated by DNA. Binding of 
one protein to DNA can accentuate the DNA flexibility and recruit other repair proteins. 
The sliding clamp protein trimer PCNA, besides functioning as an auxiliary factor for the 
DNA polymerases and thus being present in every repair pathway that require a re-
synthesis step, has also been reported to interact with specific DNA repair proteins. In 
NER, PCNA binds endonucleases XP-G and XP-A to recruit them to the lesion (72). In 
MMR, PCNA interacts with MSH2, MSH3, and MSH6 and enhances their binding 
specificity for the mismatch (73,74). While the LP-BER pathway for repairing AP sites 
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depends on PCNA interaction with RFC, Pol δ, FEN1 and Lig1 (75). In addition, APE and 
UNG interact with PCNA, supporting the idea that this protein is involved not only in re-
synthesis, but also in different steps of BER (76). PCNA can thus coordinate numerous 
proteins involved in different repair pathways, possibly through specific binding affinities, 
sub-cellular localization and PTM (e.g. PCNA ubiquitination status).  
Moreover, once the specific repair pathway is engaged, intermediate products generated 
during the processing of the lesion can be recognized as substrates for other repair 
pathways. For instance, SSBs generated during BER can be recognized and further 
processed by other repair pathways (77).  
This complex interplay requires coordination in time and space of different functions to 
create a dynamic assembly of multiple factors that ensure the maintenance of genome 
stability and cellular homeostasis.  
 
1.3 - HOMEOSTASIS: THE BALANCE BETWEEN INJURY AND REPAIR 
 
In 1929 Walter Cannon described homeostasis (homeo means "the same" and stasis 
means "standing”) as “the coordinated physiological reactions which maintain most of the 
steady states in the body” (78). When environmental changes alter the cell equilibrium, 
coordination between different networks is required for maintaining internal stability.  When 
an alteration occurs at the DNA level, homeostasis is maintained by a fine cooperation 
between DNA repair mechanisms, cell cycle progression, DNA replication, transcription, 
chromatin remodelling and apoptosis.  
When it is not possible to restore the equilibrium inside the cell, other responses such as 
apoptosis can be triggered. Excessive damage beyond a critical threshold activates 
apoptosis in a MMR-dependent fashion (79). Indeed, inactivating mutations of MSH2 and 
MLH1 are associated with hereditary non-polyposis colorectal cancer (HNPCC, also 
known as Lynch Syndrome), and leads both to an increase in the rate of spontaneous 
mutation at microsatellite, and to an inhibition of apoptosis (80). Similarly, the ATM kinase 
can trigger DNA repair or apoptosis (81). Because of their involvement in DNA repair, 
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these proteins can sense how efficiently lesions are being repaired, and establish whether 
repair functions or apoptosis signalling functions are needed to maintain tissue 
homeostasis.  
Beside apoptosis, other mechanisms are involved in homeostasis maintenance: persistent 
association of MMR proteins with its lesions can activate cell-cycle arrest (82), while a less 
toxic damage can be tolerated until the next cell cycle round (83).  
Cellular response can also differ: thymocytes are more prone to engage apoptosis in 
response to DNA damage, while primary fibroblasts appear to be more refractory, this is 
possibly related to different basal patterns of expression of pro- and anti-apoptotic 
regulators (84) or to differential DNA repair pathways activation. 
Chromatin remodelling can also be involved in the maintenance of the homeostasis: 
histones modifications that regulate protein binding to DNA, incorporation of histones 
variants, or changes in nucleosome positions can promote DNA lesion processing by 
creating a more permissive environment for DNA repair protein accessibility (25). On the 
other hand, histone H1 phosphorylation is linked to apoptosis induction, through chromatin 
changes that facilitate nucleases digestion (85). Depending on cellular context histones 
can have different effects on the homeostasis maintenance. 
Homeostasis can also be defined as the result of a balance between evolution and 
survival. Cells survival is linked to a continuous and accurate repair of the genome. On the 
other hand, inaccurate repair leads to different mutational rates and support evolutional 
segregation. In Mycobacterium tuberculosis, the acquisition of antibiotic multi-resistance is 
due to the accumulation of mutations in genes targeted by the antibiotics, thus conferring a 
selective advantage. Without errors in DNA repair mechanisms, evolution cannot occur. 
However, too many errors can lead to severe problems, including cancer (discussed in 
chapter 1.4). A fine balance has evolved to allow enough genetic variation for adaptation 
and evolution to occur.  
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1.4 - ALTERATIONS OF THE HOMEOSTASIS 
 
1.4.1- Alteration of the balance for bad 
Given that every day DNA is under the constant attack of exogenous and endogenous 
damaging agents, it is reasonable to think that alterations in the DNA repair machinery can 
have a strong impact on genome stability. Consequences of DNA repair deficiency include 
severe pathological states, such as cancer and hereditary diseases.  
 
1.4.1.1 - Alteration of the balance leading to cancer 
Genome instability and/or DNA mutation are hallmarks of all human cancers (86). When 
changes in the DNA sequence are left uncorrected, because of defective or error-prone 
DNA repair mechanisms, cells can accumulate mutations that contribute to oncogenesis. 
The relevance of DNA damage and repair to the generation of cancer is particularly 
evident since exogenous DNA damaging agent (discussed in chapter 1.1.2) can induce 
cancer. UV radiation and IR, besides modifying DNA, can induce specific cancer. Not all 
cells are equally sensitive to the damage, as radiation affects them in different ways - 
leukemia, a type of cancer that arises in the bone marrow, is the most common radiation-
induced cancer (87). Tobacco smoke is a complex mixture of different chemicals, with 
acrolein rapidly penetrating the cell membrane and binding to dG, thereby generating 
DNA-adducts that can crosslink with proteins or other DNA bases. By this mechanism, 
acrolein can inhibit DNA repair proteins scanning the lesion. Acrolein was shown to be the 
causative agent of lung and bladder cancer, in human and rat models (88).  Major 
exogenous DNA damaging agents associated with human cancer are listed in Table 3.  
Table 3 – Exogenous DNA damaging agents associated with increased risk of cancer.  
Exogenous DNA damaging agents and risk of cancer 
Exogenous DNA damaging agent Cancer with increased risk Ref 
Helicobacter pylori infection Stomach (89) 
HPV and nitric oxide from tobacco 
smoke 
Cervix/Uterus 
 (90) 
UV Melanoma (91) 
X ray Leukemia (87) 
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Besides exogenous agents, inherited polymorphisms or mutations in DNA repair genes 
may increase the predisposition to develop cancer (Table 4). Usually one defective copy of 
the gene is inherited via a parental germ cell, while the other copy is inactivated later in the 
somatic cell. 
Inherited mutations in DNA repair genes and risk of cancer 
Mutated 
Protein 
Repair pathways 
affected Cancers with increased risk Ref 
BRCA1, BRCA2 HR  Breast, ovarian (92) 
ATM HR, NHEJ Leukemia, lymphoma, breast (93) 
ATR HR Oropharyngeal (94) 
MRE11 HR, NHEJ Breast (95) 
BLM HR 
Leukemia, lymphoma, colon, 
breast, skin, esophagus, stomach, 
tonsil, larynx, lung, uterus 
(96) 
WRN HR, NHEJ, LP-BER 
Soft tissue sarcoma, colorectal, 
skin, thyroid, pancreatic (97) 
XPC, XPE NER Skin  (98) 
XPA, XPB, 
XPD, XPF, XPG NER Skin, central nervous system  (98) 
MSH2, MSH6, 
MLH1, PMS1-2 MMR Colorectal, endometrial, ovarian (99) 
 
Table 4 - Inherited mutations in DNA repair genes that increase the risk of cancer. 
Each repair pathway has its organ tropism. DNA repair pathway deficiency leads to specific 
phenotypical manifestation even if deletion occurred at the germinal level.  
 
One of the best documented examples of the association between inherited mutation in 
DNA repair genes and cancer is HNPCC, in which mutations in MMR genes give rise to 
microsatellite instability (MSI) (100). Germline alteration in any of five human MMR genes 
(MSH2, MLH1, MSH6, PMS2 and PMS1) can result in HNPCC (100). MMR deficiency 
leads to an increase in the mutation rate, with frameshift mutations generating multiple 
repetitions of short sequence unit (one to six nucleotides long), called microsatellites. If 
mutations occur in exonic coding sequences of tumour suppressor genes, tumour 
development is favoured.   
Mutations in DNA repair genes have tissue specificity: mutations in MMR lead to colorectal 
cancer, whereas mutations in proteins involved in SSBR impair the non-dividing 
neurological cells (101). Tissue specificity is likely due to the concurrence of different 
factors, such as the proliferation rates, the exposure to mutagens, or the expression levels 
of genes that contains short repetitive sequences. 
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Proteins in the DNA repair pathways can also contribute to carcinogenesis when their 
ability to initiate apoptosis in response to DNA damage is impaired (102), with a decrease 
in apoptosis playing an important role in tumorigenesis. MSH2 deficiency induce 
accumulation of genomic mutations and impairment of apoptosis signalling, thus resulting 
in a fast tumorigenic phenotype; while Lin et al. studied an MSH2 mutant mice model, 
unable to activate MMR, but still able to perform apoptosis and resulting in slow 
tumorigenic phenotype (103). 
 
1.4.1.2 - Alteration of the balance in inherited diseases 
Besides cancer, DNA repair-deficiencies can be associated with several rare hereditary 
diseases such as neurodegenerative disorders and immune-deficiencies. While, 
phenotypes arising from DNA repair-deficiencies include sensitivity of the skin to sunlight. 
In the central nervous system (CNS), due to high glucose metabolism, neurons have a 
pronounced oxygen metabolism. NER and BER deficiencies can lead to an increase in 
oxidative DNA damage leading to neurodegenerative disorders, e.g. Xeroderma 
pigmentosum (XP) and (Cockayne syndrome) CS (104). Ataxia telangiectasia (AT) can 
arise when ATM is not activated in response to DSBs, thus resulting in reduction of repair 
and prevention of apoptosis. This is particularly deleterious in brain, where accumulation of 
damaged cells leads to neurodegeneration (105), while in the immune system AT leads to 
immunodeficiency, due to defects in B cell maturation.  
 
1.4.2 - Alteration of the balance for good 
Evolution can be based on mutations introduced by errors in DNA repair mechanisms. If 
the mutational process is controlled and programmed, genetic variation, and thus the 
alteration of the homeostasis, can have a positive impact on the organism. It is known that 
specific DNA sites are particularly prone to mutation (hot spots), thus providing a substrate 
for mutability. Moreover, to confer a selective advantage, a mutation should be positively 
selected, reducing the probability of a deleterious impact. Meiotic recombination and Ig 
locus diversification are examples of mechanisms that confer a selectively advantageous 
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variability, with HR playing an important role in increasing genetic variability by allowing 
gene recombination. 
 
1.4.2.1 - Alteration of the balance in meiosis 
During meiosis, a reproductive cell containing a diploid number of chromosomes 
generates four haploid cells, each containing a single set of chromosomes. Each of the 
four resulting cells differs from the other three because of genetic recombination. 
Reciprocal genetic exchange of chromosomal fragments was observed for the first time in 
Drosophila in 1931 (106). During prophase of the first meiotic division, when homologue 
chromosomes are aligned, programmed DSBs are introduced throughout the genome by 
the meiotic topoisomerase-like protein SPO11. Analogous to somatic HR, the 5’ ends are 
resected to generate 3’ single-stranded tails (61). After the scanning of the homologous 
duplex, strand invasion leads to the formation of a D-loop structure. D-loops can be 
resolved through crossing-over (CO) mechanism, with reciprocal exchange of large DNA 
sequences, or through a non-CO mechanism, which involves a unidirectional transfer of 
short DNA sequences (or gene conversion). Most recombination events are concentrated 
on defined hotspot sequences, thus only loci flanking an hot spot undergo recombination 
events (107). Hence, programmed DSBs formation is regulated both temporally (with 
respect to meiotic progression) and spatially. Genetic diversity is further enhanced during 
the first meiotic division, when each chromosome homologue randomly segregates. 
 
1.4.2.2 - Alteration of the balance in Ig locus diversification 
Every day our antibodies successfully recognize millions of different antigens, including 
pathogens, with each immunoglobulin (Ig), specifically recognizing an epitope on the 
surface of an antigen. To obtain this diversity during development, the Ig-producing cells or 
B-lymphocytes undergo a physiological process of targeted and regulated alterations of 
the Ig locus (termed Ig locus diversification). 
Igs are composed of four polypeptide chains, two heavy chains and two light chains linked 
via disulphide bridges (Figure 4). There is a single heavy chain locus (IgH) and two light 
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chain loci (Igκ and Igλ) in the human genome. The IgH sub-class (µ, δ, γ, α, ε) define the 
effector function of the antibodies, called IgM, IgD, IgG, IgA and IgE, respectively. 
 
Figure 4 - Ig locus organization and protein structure  
Heavy-chain (IgH) variable (V) regions are constituted of three gene segments: V,(D) and J (red to 
orange VH). The constant (C) region consists of one of several several segments (µ, δ, γ, α, ε). 
Light-chain (IgL) V-region genes are constituted of two segments V and J (orange and yellow) and 
form the light chain peptide with a C segment. The antibody is composed of two heavy chains 
(dark blue) and two light chains (light blue). Black bars mark disulphide bridges 
 
 
The development of B cells from progenitor cells to functionally mature B cells takes place 
in the bone marrow. Here, B cells undergo successive programmed rearrangements, first 
in IgH and then in IgL locus. Variable (V), diversity (D) and joining (J) gene segments in 
the IgH locus join randomly to assemble the pre-B cell receptor (108). V(D)J recombination 
is catalysed by the proteins RAG1 and RAG2, which introduce DSBs at recombination 
signal sequences (RSSs) that flank each V, D and J gene segment. These DSBs are 
substrate for TdT polymerase, which adds random nucleotide to the DNA ends, and 
subsequently the segments are joined through NHEJ, thus the repair is imprecise (109). 
Overall diversity depends on recombinatorial shuffling of of V, D, and J segments, and on 
the imprecise joining of those segments. After an analogous VJ rearrangement of the κ or 
© Adapted from K. Willmann - UCL
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λ light chain, a complete IgM is expressed on the surface of B cells. However, 55 to 75 % 
of the B cells emerging from the bone marrow are self-reactive (110) and undergo 
apoptosis. The surviving B cells leave the bone marrow for the periphery, where after 
antigen encounter, they undergo further steps of diversification.  
 
In the germinal centres (GC) of lymphoid organs, the DNA in the Ig loci of B cells undergo 
two important processes known as somatic hypermutation (SHM) and class-switch 
recombination (CSR) (reviewed in (111) – Figure 5).  
  
Figure 5 - Schematic drawing of SHM and CSR 
A) SHM introduces point mutations in V genes. Mutations are shown as red vertical lines in the V 
segment. B) CSR occurs between switch regions located upstream of the different C region (pink 
and light blue circles). Rearrangement to a different C region results in isotype switching. The 
intervening DNA sequence is released as a circular episome. 
 
SHM introduces point mutations into the V(D)J exon of IgH and IgL, resulting in 
differentially mutated variable regions unique for each B cell, thereby creating a novel B 
cell repertoire (112) (Figure 5A). Only B cells expressing antibodies with higher affinity for 
specific antigens are clonally expanded. Alternatively, B cells can also undergo CSR, 
© Adapted from Petersen-Mahrt, S. (2005) Immunol. Rev
B
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where the initially expressed IgH constant region (µ) is exchanged with one of the 
alternative downstream regions (δ, γ, α, ε), thus changing the Ig isotype from IgM to IgD, 
IgG, IgA or IgE. The choice of the particular isotype being selected is according to the 
extracellular signals received by cytokines (113) (Figure 5B). CSR and SHM are initiated 
by activation-induced deaminase (AID), a member of the AID/APOBEC family of cytosine 
deaminases (114). This enzyme introduces DNA lesions by deaminating dC into dU in 
DNA (Figure 6 - discussed in chapter 1.5). 
It is clear that introduction of controlled and beneficial mutations has a positive impact on 
the selection and evolution of antibodies, that enhance the recognition of antigens with 
high efficiency. Moreover, individuals without AID or with a mutated version of the gene 
develop hyper IgM syndrome and a mild immunodeficiency (115). Thus perturbation of the 
homeostasis is necessary for survival and evolution. 
 
1.5 - THE NATURAL DNA MUTATOR AID  
 
AID is the protein that best recapitulates the necessity of a balance in DNA stability to exist 
between survival and evolution. The consequences of AID activity, both in physiological 
and pathological situations, will be discussed below more in details. 
 
1.5.1 - AID in immunity 
AID is a 24 kDa enzyme discovered in 1999, while screening for genes that are 
upregulated upon CSR in CH12 mouse B lymphoma cells (114). Its DNA deaminase 
activity was elucidated in vitro and in vivo years later (116-118). The DNA substrates that 
are recognized by AID are well defined: including dC, 5FdC and 5mdC (119,120). In vitro, 
AID deaminase activity was shown to be distributive, rather than processive (121), 
meaning that rather than moving along the DNA towards the next target, it dissociates 
from its substrate after each deamination and reassociate with the template at a different 
site. Another group proposed a jumping and sliding model: AID was hypothesized to bind 
ssDNA and move bidirectionally, moving or jumping to a distal part of the molecule without 
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disassociating (122). Catalytic activity is harboured within the cytosine deaminase domain, 
which includes a zinc co-ordinating motif and histidine 56 (H56) and glutamic acid 58 
(E58). The C-terminal portion of AID contains a nuclear export signal (NES), and was 
shown to be essential for CSR (123). The N-terminus contains a nuclear localization signal 
(NLS) and is essential for SHM (124). AID requires ssDNA as a substrate, which in vivo, 
during Ig locus diversification, seems to be provided by the concomitant transcription 
elongation process (51,125-128). Moreover, in hypermutated Ig genes, dC is more 
frequently targeted in the context of WRC (W= dA or dT; R = dA or dG), a sequence 
preference that was also observed in vitro experiments (120,129). Once dC, in the 
preferred context of WRC is accessible, AID deaminates dC to dU, leading to the 
formation of a dU:dG mismatch in dsDNA (Figure 6). 
	   
Figure 6 - Reaction catalysed by AID 
The catalytic activity of AID in ssDNA produces a uracil from a cytosine by hydrolytic deamination. 
AID deaminates the HN3 at the C4 position in the pyrimidine ring. This results in a dU:dG 
mismatch in dsDNA. 
 
If DNA replication occurs before mismatches recognition, a transition from dC to dT will 
take place. A mechanism through which most of the mutations are generated in phase 1a 
of SHM (112). Otherwise, in phase 1b of SHM, dU can be recognized and excised by UNG 
glycosylase and partially processed by the BER pathway (130); if replication occurs after 
the AP site generation, the polymerase can incorporate any base and transversion 
(interchange of a purine with a pyrimidine base, e.g. dC to dA) or transition (interchange 
within purine or within pyrimidine bases, e.g. dC to dT) mutations can occur. Replication 
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past AP site requires the polymerase to incorporate a base without a template; this could 
involve either normal replicative polymerases or translesion polymerases (131,132). This 
mutagenic process was confirmed by the fact that although deamination takes place at dC, 
mutations at dC/dG and dA/dT basepairs are observed with equal frequency in vivo and 
transitions are slightly more frequent than transversions (133), with UNG deficient mice 
displaying altered SHM (130).  SMUG1 glycosylase can also remove dU from both dU:dG 
mismatch and dU:dA pairs, but has a very low turnover number compared to UNG(134), 
and has been shown not to partake in SHM (135). 
Furthermore, in phase 2 of SHM, dU:dG mismatches or the AP site can be recognized by 
other repair pathways. When the MMR machinery is recruited (45,47), mutations at A/T 
near the initiating U/G lesion are generated. Indeed, deficiency in MSH6 (136), DNA Pol η 
(132), or EXO1 (46) leads to a reduction in the accumulation of mutations at AT pairs in Ig 
genes. In MSH2-/- residual mutations at AT pairs are observed, probably because LP-BER 
is involved through PCNA interaction in error prone polymerases recruitment. 
Moreover, while UNG-/-/SMUG-/- mice are viable and fertile, UNG-/-/SMUG-/-/MSH2-/- triple 
knock-outs have a shortened lifespan, mostly because of cancer development (137). This 
data demonstrate that MMR may serve as an ultimate backup in repair of dU lesions. 
The model of error-prone ncMMR at Ig locus (53) was discussed in chapter 1.2.2.2. 
However, recently it has been demonstrated that UNG and MSH2 contribute both to error-
free and error-prone repair (138), possibly via different accessibility of polymerases to the 
damaged locus. Further studies showed that in the presence of the hMutSα complex 
dU:dG mismatches in the Ig locus are repaired with high fidelity, while in the absence of 
the MSH2/MSH6 heterodimer error-prone repair is favoured (139). This balance between 
error-free and error-prone repair may be a protective mechanism, to avoid excessive Ig 
locus mutagenesis and subsequent malignant transformation of B cells. This also implies 
that SHM is an active mutagenic process, rather than a failure in the maintenances of the 
fidelity of DNA replication. 
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1.5.2 - AID outside of the immune system 
 
1.5.2.1 - AID in epigenetic reprogramming 
The discoveries that induction of AID expression can be stimulated by estrogen (140) and 
that AID associates with proteins that are not part of B cell development, suggested for 
AID to have a function outside the immune system. Indeed, AID was found to be 
expressed not only in immune tissues, but also in oocytes and primordial germ cells 
(PGCs) (120). In PGCs, AID was linked to epigenetic reprogramming and active DNA 
demethylation, because of its ability to deaminate 5mdC (120). Deamination of 5mdC by 
AID generates dT, which in the context of dsDNA results in a dT:dG mismatch. This lesion 
could be recognized by TDG and MBD4 glycosylases, which can excise the dT and 
generate an AP site that is repaired with a non-methylated dC. Indeed, TDG-/- mice exhibit 
impairment in global methylation and embryonic lethality (141); while in AID-/- mice the 
content of 5mC in PGCs is increased by 30 % (142). dT:dG lesions and AP sites can also 
be recognized by proteins involved in MMR, translesion synthesis, or NHEJ. The 
consequence of recognition of dT:dG by non-BER pathway is the discovery that 
processive DNA demethylation can be induced by AID (143). Mice expressing a G-AID 
fusion protein were bred with mice harbouring the GAL4 binding site (UAS) inside the 
methylated H19 locus. Subsequent analysis of the methylation status of the DNA 
surrounding the UAS region was performed. Significant processive demethylation 
dependent on G-AID catalytic activity was observed (143). Since AID was shown to be 
non-processive (121), the processive demethylation can only be the result of the activated 
repair mechanisms (Figure 7). While the SP-BER pathway will produce a single 
demethylation event, the processive repair replaces long stretches of all bases, including 
those surrounding the 5mC, leading to multiple demethylation events. Furthermore, 
demethylation can also be achieved indirectly, with AID targeting a non-modified dC: 
activation of the same processive repair mechanisms will lead to extensive removal of 
surrounding bases, including the methylated ones (143). This model reduces the number 
of DNA damages initially required and explains the efficiency of DNA demethylation.  
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Figure 7 - Model for lesion-induced DNA demethylation  
AID can target both normal cytosine (green panel) and methylated cytosine (red panel). Different 
lesions are generated, (dU and dT:dG mismatch) and depending on the repair mechanism 
recruited, resolution can be processive or not. Independently from the targeted base, if processive 
polymerases dependent repair is recruited, several bases surrounding the lesion (including the 
methylated cytosines) are removed and replaced with normal bases (white circles), leading to 
DNA demethylation.  
 
This fully support the notion that downstream lesion resolution and activation of DNA 
repair pathways determine the outcome of AID activity. As DNA methylation has important 
regulatory functions in development and in the control of gene expression, DNA 
demethylation is a necessary counterbalance for epigenetic marks on DNA. 
 
1.5.2.2 - AID in cancer 
AID is a natural DNA mutator, designed to introduce genomic instability into a defined 
locus, thus misregulation of its activity can easily lead to severe pathological outcomes, 
including cancer. Alteration of AID function can occur both in B cells, while AID is carrying 
out its natural function leading to B cell malignancies, and when AID is activated outside of 
the immune system. As a result of aberrant CSR, many B cell malignancies bear 
© Adapted from Franchini D.M. et al. (2014) PLoS One
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chromosomal translocations that join the highly transcribed Ig locus with portions of proto-
oncogenes (144). Burkitt’s lymphoma is characterized by translocation between the c-myc 
oncogene and the IgH locus. AID expression was found to increase c-myc/IgH 
translocations, and AID was shown to be essential for the DSBs generation in c-myc that 
result in those translocations (145). In addition to c-myc, a subset of other Ig and non-Ig 
genes undergo aberrant hypermutation or translocation in B cells, including BCL6, FAS 
and PAX5 (146). Moreover, AID is also required for tumour progression in different 
leukaemia’s, such as chronic myeloid leukaemia (147) and chronic lymphocytic leukemia 
(148). Here, the acquired mutations resemble those introduced by SHM, as they are 
predominantly in the WRC hotspots and are transition mutations. 
Constitutive expression of AID in mice leads to various tumour formation, such as lung T-
cell (149), liver (150) and gastric cancer (151). Furthermore, Helicobacter pylori infection 
has been shown to trigger NFκB-dependent upregulation of AID, which lead to gastric 
cancer (151). Diversification of tumour formation let us hypothesize that there is a specific 
cell susceptibility to AID-induced lesions. Moreover, bioinformatics analysis of the dC to dT 
transitions occurring in p53 and APC genes (in different human cancers) reveal similarities 
between the mutation spectrum of those genes and AID/APOBEC preferential targets 
(152). Moreover, recently, the TC sequence context of the mutations generated by 
APOBEC3A and APOBEC3B was related to signatures of localized hypermutation, in 
human breast cancers (153).	   This possible tumorigenic mechanism is defined by the 
outcome of AID lesion resolution, with inefficient repair and fixation of a mutation.	  
Alteration of the balance between survival and evolution, with AID overexpression or AID 
depletion can severely affect our health, ranging from autoimmunity (review in (154)) to 
tumour formation and, in the worst scenario, lethality. Natural AID lesions can lead to the 
activation of repair pathways, recombination, or mutation, each in its physiological context.  
 
 
 
 
INTRODUCTION 
	   	  	  	   42 
1.6 - Current State 
As previously discussed, downstream lesion resolution and DNA repair specific activation 
determine the outcome of AID activity. Regulation of AID damage repair can occur at 
different levels: depending on where the damage is located, the cellular microenvironment, 
or chromatin interference a different outcome can be expected.  
♦ dU:dG mismatches in non-Ig loci usually lead to proper DNA repair and reversion to 
dC, with the spontaneous deaminations that occur every day in every cell being 
efficiently repaired.  
♦ Aside from the location of the AID-induced damage (e.g. Ig locus), the cellular milieu 
(e.g. B cells) plays an important role in lesion processing. This was shown when AID-
induced dU:dG mismatches in the post-replicative meiotic nuclei cause an induction of 
meiotic recombination (155), while the same damage in replicative germ cells is 
repaired. Indicating that cells have variable sensitivity for DNA damage depending on 
the presence or absence of a single repair pathway, leading to efficient or inefficient 
lesion processing.  
♦ It is known that the chromatin structure influences both the recruitment of DNA repair 
mechanisms and the accessibility to the lesion. It has been reported that hMutSα can 
lead to fluctuation in the nucleosome positioning, with the rate of disassembly being 
enhanced by histone H3 acetylation (156). It is possible that chromatin remodelling 
interact with MMR protein, coordinating repair with other metabolic processes, such as 
DNA replication and transcription. 
♦ Moreover, cell cycle checkpoints are activated upon DDR, and DNA repair protein 
expression in different phases of the cell cycle may have a role in directing AID-
damage resolution. AID localizes at the IgH locus during the G1 and early S phase in 
splenic activated B cells (157), hence AID could coordinate UNG and MMR proteins 
that are present in the G1 phase of the cell cycle (158). However, it is not clear, if 
error-prone repair occur preferentially during replication, a time when DNA is more 
accessible. Post-translational modification, such as phosphorylation and ubiquitination 
may modulate the DNA damage response in a spatial and temporal manner.  
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AIM  
DNA damage is a prerequisite for physiological processes during meiotic recombination, Ig 
locus diversification, and epigenetic reprogramming. On the other hand, DNA damage is a 
major threat for a cell, as it can lead to genomic instability, including DSB-induced 
translocation or mutation. In each case the DNA damage response plays a crucial role in 
the outcome, but the mechanisms that govern error-free versus mutagenic processing of 
uracil remain obscure. Several molecular pathways can contribute to uracil lesion 
resolution, such as cell environment, location of the damage, sequence specificity, 
chromatin conformation, specific signal transduction, protein interacting with repair 
pathways, rate of mutations, cell replication state and many others. 
The aim of my PhD thesis was to investigate the cited molecular pathways that could 
explain the cellular differences that, upon AID lesion resolution, lead to repair, 
recombination, or mutation.  
To this end, I decided to use AID as a tool and study AID for its physiological functions. As 
a tool, DNA deaminases provide two important aspects not previously utilised in the DNA 
repair field: 1) DNA deaminases are the only fully physiological lesion generating proteins 
known, 2) they produce only one type of lesion in non-modified DNA deaminated cytosine 
bases. These specific points allow us to control DNA lesion generation and resolution, and 
provide novel insight into the Ig dependent AID-lesion resolution. The aim was to directly 
target a plasmid DNA with AID to introduce dU:dG mismatches and determine how 
different cell extracts in different conditions respond to the damage leading to DNA repair. 
The working hypothesis is that the distribution of mutation versus repair is determined by a 
balance between recruitment of high fidelity versus error prone repair systems. This 
balance can be moved toward repair or introduction of mutation depending on cell context, 
interacting factors, access of polymerases to the target locus, DNA methylation, 
nucleosomes formation, and other factors yet not identified. 
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CHAPTER 2 – MATERIALS AND METHODS  
 
2.1 - MATERIALS 
All media or buffers marked with “*” were prepared by IFOM kitchen 
 
2.1.1 - Buffers and reagents 
2 M NaCl buffer: 2 M NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT 
1 M NaCl buffer: 1 M NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT 
0.65 M NaCl buffer: 0.65 M NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT 
0.2 M NaCl buffer: 0.2 M NaCl, 10 mM Tris-HCl pH 8.0, 1 mM EDTA, 1 mM DTT 
CALBIOCHEM® EDTA-free protease Inhibitors* 
Coomassie Brilliant Blue solution*: 50 % methanol, 10 % glacial acetic acid, 40 % 
water, 0.25 % coomassie blue R-250 
De-staining solution*: 25 % methanol, 7.5 % glacial acetic acid, 87.5 % water 
Dejellying Buffer: 10 mM Tris-HCl pH 8.5, 110 mM NaCl, 5 mM DTT 
Elution Buffer: 20 mM MES pH 6.0, 700 mM NaCl, 150 mM KCl, 2.5 mM TECP, 1.6 mM 
CHAPS, 300 mM L-arginine HCl, 5 % glycerol, 200 mM imidazole; filtered with a 0.2 µm 
filtering device and adjusted at pH 6.0 
Extraction Buffer: 20 mM MES pH 6.0, 700 mM NaCl, 150 mM KCl, 2.5 mM TECP, 1.6 
mM CHAPS, 300 mM L-arginine HCl, 5 % glycerol, 10 mM imidazole. Filtered with a 0.2 
µm filtering device and adjusted at pH 6.0. Freshly added 50 mg/L RNAse A and 
CALBIOCHEM® EDTA-free protease inhibitors (1:500) 
Fushin Formamide: 0.1 % fushin dye (Sigma) 10 mM Tris-HCl pH 8 in formamide 
Hypotonic Buffer: 10 mM Tris-HCl pH 7.5, 3 mM CaCl2, 0.32 M sucrose, EDTA-free 
protease inhibitors (1:500) 
IVR buffer 5X: 50 mM NaCl, 200 mM Tris-HCl pH 8.0, 400 mM KCl. Freshly added 0.005 
mM DTT and 5 µg/µl RNAse A 
Laemmli buffer: 10 % SDS, 50 % glycerol, 0.1 % bromophenol blue, 50 mM DTT, 150 
mM Tris-HCl pH 6.8. 
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Lysis Buffer: 0.1 M Tris-HCl pH 8.0, 5 mM EDTA, 200 mM NaCl, 0.2 % SDS. Freshly 
added 0.1 mg/ml of proteinase K 
MMR Buffer: 10 mM Hepes-KOH pH 7.5, 200 mM NaCl, 1 mM KCl, 0.5 mM MgSO4, 1 
mM CaCl2, 0.05 mM EDTA.  
PBS 1x: 10 mM phosphate, 137 mM NaCl, 2.7 mM KCl pH 7. 
R Buffer 5x: 250 mM NaCl, 15 mM MgCl2, 200 mM Tris-HCl pH 8, 200 mM KCl, 5 mM 
DTT, 10% glycerol 
Running Buffer*: 25 mM Tris-HCl pH 8.6, 190 mM glycine, 0.1 % SDS 
S-Buffer: 50 mM Hepes-KOH pH 7.5, 50 mM KCl, 2.5 mM MgCl2, 250 mM sucrose. 
Freshly added 2 mM β-mercaptoethanol and 15 µl/mL leupeptin.  
TBE* 1x: 89 mM Tris-HCl pH 8, 89 mM boric acid, 2 mM EDTA 
TBS 1x: 50 mM Tris-HCl pH 7.5, 150 mM NaCl 
TBST 1x: 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1 % Tween 20 
TE*: 10 mM Tris-HCl pH 8.0, 0.1 mM EDTA 
TE-0: 10 mM Tris-HCl pH 8.0, 0.1 mM EDTA, 0.01 % Tween-20 
TE-50: 10 mM Tris-HCl pH 8.0, 0.1 mM EDTA, 0.01 % Tween-20, 50 mM NaCl 
TE-100: 10 mM Tris-HCl pH 8.0, 0.1 mM EDTA, 0.01 % Tween-20, 100 mM NaCl 
TE-500: 10 mM Tris-HCl pH 8.0, 0.1 mM EDTA, 0.01 % Tween-20, 500 mM NaCl 
TE-1000: 10 mM Tris-HCl pH 8.0, 0.1 mM EDTA, 0.01 % Tween-20, 1 M NaCl 
TEN Buffer: 10mM EDTA, 50 mM Tris-HCl pH 7.5, 1M NaCl 
Transfer Buffer*: 25 mM Tris-HCl, 192 mM glycine, 20 % methanol, pH 8.3 
Washing Buffer: 20 mM MES pH 6.0, 700 mM NaCl, 150 mM KCl, 2.5 mM TECP, 1.6 
mM CHAPS, 300 mM L-arginine HCl, 5 % glycerol, 10 mM imidazole; filtered with a 0.2 
µm filtering device and adjusted at pH 6.0 
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2.1.2 - Plasmids 
Plasmids used in this thesis are schematically depicted in Figure 8. pSPM589 (159) was 
constructed by S.Petersen-Mahrt (the DNA-binding domain of GAL4 was inserted into the 
NcoI restriction site of AID-His in pSPM75 - a pET30 derived vector), pDMF1620 [REF of 
IVR paper] was constructed by D.M. Franchini (the catalytic inactive GAL4-AID C87R was 
created by site-directed mutagenesis from pSPM589), and pGL4.31 was purchased from 
Promega (UK). pEI7150 and pEI7151 were cloned substituting 2 kB of pGL4.31 with 1.1 
kB of PCR amplified low/high nucleosome forming regions (LN/HN) from chicken kappa 
and lambda Ig locus. For the rifampicin assay pETduet (Addgene) and pDS4501 
(expressing hAID WT) were used. 
 
Figure 8 – Schematic drawing of plasmids 
pSPM589 was cloned adding the cDNA sequence for human AID (hAID) to the DNA binding 
domain of GAL4 (GAL4); additional tags were added for specific isolation: P = protein C tag, T = 
TEV sequence to cut off tags from the protein, F = Flag tag, H = His-tag. KanR = Kanamycin 
resistance cassette. pDMF1620 is identical to pSPM589 with exception of a missense mutation 
E58Q. pEI7150 and pEI7151 were cloned substituting 2 kB of pGL4.31 with 1.1 kB of PCR 
amplified low/high nucleosome forming regions (LN/HN) from chicken kappa and lambda locus. 
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2.1.3 - Oligonucleotides 
Oligonucleotides used in this thesis are listed in Table 4 
 
NAME OLIGONUCLEOTIDE SEQUENCE LENGTH 
ORIENTA
TION APPLICATION 
1512 GGCCTAACTGCCCGGTAC 18 F qPCR (IVR with pGL4.31) 
1518 GTCCACCTCGATATGTGC 18 R qPCR (IVR with pGL4.31) 
7290 CCCCCACCCCCTTTTATAG 19 R 
qPCR (IVR with 
pEI7151 and 
pEI7150) 
163 bioATTATTATTATTAGCTATTTATTTATTTATTTATTTATTTfluor 40 F 
ssDNA 
oligonucleotide 
deamination 
ASSAY  
164 bioATTATTATTATTAGUTATTTATTTATTTATTTATTTATTTfluor 40 F 
dsDNA 
oligonucleotide 
glycosylases 
ASSAY  
166 AAATAAATAAATAAATAAATAATAGCTAATAATAATAAT 39 R 
dsDNA 
oligonucleotide 
glycosylases 
ASSAY  
7175 AAACAATTGCAGTCCTCCCCAGCAGTAAG 29 F 
Construction 
pEI7151 
7176 
ATACGGAGCTTAAGTTATTAG
ACGTCCAATGCAAAAACCTC
CCACT 
46 R Construction pEI7151 
7195 
 
 
TTGCATTGGACGTCTAATAAC
TTAAGGCTCCGTATCACTGTG
TGGTATAT 
50 F Construction pEI7151 
7196 GAAAGATCTATTTCACCCCCAAGGACACT 29 R 
Construction 
pEI7151 
7179 AAACAATTGGCTGAGAGGAATATTTTGTCA 30 F 
Construction 
pEI7150 
7180 
CTCAACCCCTTAAGTTATTAG
ACGTCTCGGGCTCTTTCTAC
CTCAA 
46 R Construction pEI7150 
7181 
GAGCCCGAGACGTCTAATAA
CTTAAGAAATTGAGTGCTTTT
TCTTTGAA 
49 F Construction pEI7150 
7182 GAAAGATCTAAACACATCCACCCATCCAT 29 R 
Construction 
pEI7150 
7100 GCTTTAATGCGGTAGTTTATCA 22 F 
cDNA 
amplification for 
transcriptional 
activity assay 
7101 CGTAGTCGATAGTGGCTCCAA 21 R 
cDNA 
amplification for 
transcriptional 
activity assay 
Table 4 – oligonucleotides length, orientation and applications. 
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2.1.4 - Antibodies  
Antibodies used for Western Blot are indicated in table 5.  
 
ANTIBODY MANUFACTURER CONCENTRATION/ DILUTION 
Mouse monoclonal anti-HIS 
HRP conjugated sc-8036, Santa Cruz 1:1000 
Mouse monoclonal anti-AID 
STR9 Bernardo Reina-S-Martin 1:10000 
Rabbit polyclonal anti-MBD4 
ab12187, Abcam 0.5-1 ug/ml 
Rabbit polyclonal anti-UNG 
ab123668, Abcam 2 ug/ml 
Rabbit Polyclonal anti-EXO1 AP20554PU-N, Acris Antibodies GmbH 1-5 µg/mL 
Rabbit polyclonal anti-H3 ab1791, Abcam 1:10000 
Mouse monoclonal anti-alpha 
Tubulin Sigma* 1:5000 
anti-PhosphoSerine ab17464,abcam 1:1000 
Table 5 – Antibodies, manufacturers and concentration used.  
*was supplied by IFOM kitchen. 
 
2.1.5 - Chemical Inhibitors 
Chemical inhibitors used for cell cycle synchronization (Nocodazole) and inhibition of 
specific DNA repair pathways are listed in table 6 
 
INHIBITORS MANUFACTURER 
Nocodazole M1404-2MG, Sigma 
Uracil Glycosylase Inhibitor (UGI) M0281L, Euroclone 
T2 amino alcohol PCNA Inhibitor (T2AA) 
Naoaki Fujii 
Aphidicolin 
A0781-1MG, Sigma 
Table 6 – Chemical inhibitors and manufacturers.  
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2.2 - METHODS 
 
2.2.1 - Cell culture 
Cell thawing 
A cryotube with cells was thawed quickly in a waterbath at 37 °C and immediately 
transferred to a 15 mL Falcon Tube with 10 mL warm culture medium. Cells were 
collected by centrifugation at 1200 rpm for 5’ and the supernatant was aspired. The cell 
pellet was resuspended, accordingly to cells density, in fresh media and transferred in 
culture device.  
Cell freezing 
Cells were centrifuged at 1200 rpm for 5’ and the supernatant aspired. Cells were gently 
resuspended in 1 mL of freezing medium (10 % DMSO and 20 % FCS in culture medium) 
and transferred in a cryotube, which was placed in a NALGINI Freezing Container 
containing isopropanol for 72 h at -80 °C. Vials were then transferred into liquid nitrogen 
tank.  
Culturing cells in suspension  
Cells were monitored on a daily base analysing morphology, cell density and changing in 
the colour of the culture medium. Live and death cells were counted using Tryphan Blue 
solution and hemocytometer. Cells were cultured at 37 °C with 5 % CO2 and medium was 
always warmed at 37 °C prior to adding it to cells.  
Ramos (human Burkitt’s lymphoma) cell line was maintained at 2 x 105 in RPMI 1640 
supplemented with 10 % FCS from South America (SA), 2 mM L-Glutamine, 10 mM 
HEPES pH 7.5, 1 mM Sodium pyruvate and 5 % Penicillin/Streptomycin.  
BL2 (human Burkitt’s lymphoma clone 2) cell line was maintained at 2 x 105 in RPMI 1640 
supplemented with 10 % FCS SA, 2 mM L-Glutamine and 5 % Penicillin/Streptomycin.  
HelaS3 (human cervix epithelial carcinoma) and Colo704 (human ovarian 
adenocarcinoma) cell lines were maintained at 4 x 105 in DMEM supplemented with 10 % 
FCS SA, 2 mM L-Glutamine and 5 % Penicillin/Streptomycin. 
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Chicken bursal derived DT40 cell line was maintained at 5 x 105 in DMEM/F-12 
Glutamax™ supplemented with 10 % FCS SA, 5 % Chicken Serum (heat inactivated 30’ 
at 55 °C), 5 % Penicillin/Streptomycin and 50 µM β-Mercaptoethanol.  
Cell synchronisation 
Ramos and HelaS3 cell lines were grown at 2 x 105 at different concentrations of 
Nocodazole (0-100 ng /mL) and cell number was counted at different time points (0-24h). 
Nocodazole 1mg/mL was diluted in 20 % DMSO and 80 % growing medium. After testing, 
Final synchronization occurred with 40 ng/mL Nocodazole 14h or 17 h (for Ramos and 
HelaS3 respectively). 
Cell extract Preparation 
Cells were grown to reach density of 1-5 x 10^8 and were collected by centrifugation in 
500 mL bottles at 1200 rpm for 10’. Cell pellet was washed with 50 mL ice-cold 1x PBS 
and after centrifugation the packed cell volume (PCV) was measured. After measurement, 
Hypotonic Lysis Buffer (5 times PCV) was added to the pellet, which was properly 
resuspended. Pellet were incubated 12’ on ice and at 4 °C to allow cells to swell. After 12’, 
10 % Triton X-100 in Hypotonic Lysis Buffer was added to the pellet dropwise to a final 
concentration of 0.3 %. The suspension was mixed and incubated for 3’ on ice at 4 °C. 
After 3’ the suspension was centrifuged at 2500 rpm and supernatant, named cellular 
extract, was collected and was stored in liquid nitrogen. 
 
2.2.2 - Cell staining 
Propidium Iodide (PI) and Caspase 3 staining: 106 cells were harvested and centrifuged at 
3000 rpm for 5’. Cells were washed once in 1mL of cold PBS before incubation for 20’ on 
ice with formaldehyde 1 % in 1x PBS. Cells were then washed in PBS 1 % BSA and 
resuspended in 250 µL of PBS and 750 µl of cold ethanol (added dropwise and slowly 
while vortexing, to avoid aggregate formation). Cells were left in fixative 30’ on ice, 
washed in 1mL PBS 1 % BSA and permeabilized with 100 µL of TritonX 0.1 % in PBS 10’ 
at RT. After another wash in PBS 1% BSA the cells were resuspended in 500 µL of Goat 
Serum 10 % in PBS. After 30’ cells were centrifuged 3000 rpm 5’ and the pellet was 
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resuspended in 100 µL antibody anti caspase3 diluted 1:50 in PBS 1 % BSA and 
incubated for 1h at RT. Cells were then washed in PBS 1 % BSA and incubated with 100 
µl anti-rabbit FITC diluted 1:50 in PBS 1 % BSA 1h at RT protected from light. Cells were 
finally washed in PBS 1 % BSA and resuspended in 500 µL PI (2.5 µg/mL) (diluted in PBS 
with 250 µg/mL RNAse) and kept at 4 °C until FACS analysis. FACS was performed by 
IFOM imaging unit. 
 
2.2.3 - In vitro transcription assay 
The in vitro transcription assay was performed using HeLaScribe® Nuclear Extract in vitro 
Transcription System (Promega), but instead of using a radioactive detection system we 
performed RT-qPCR. Hela Nuclear Extract Positive Control DNA (containing a CMV 
promoter) was added to a reaction mix containing: 1x transcription buffer, 2 mM MgCl2, 
0.4 mM rNTPs and 35 µg of cellular extracts. The mix was incubated at 30 °C for 60’ and 
the reaction was stopped by adding 175 µL of Stop Solution. RNA was extracted with 200 
µL of phenol:chloroform:isoamyl alcohol (25:24:1) and RNA was precipitated with 700 µL 
of 100 % ethanol. After centrifugation at 14000g for 10’ pellet was resuspended in 10 µL 
of Nuclease-Free water. DNA was removed using RQ1 RNase-Free DNase treatment 
(Promega) following the manufacturer’s instruction. Reverse transcription of extracted 
RNA was performed with SuperScript® VILO cDNA Synthesis Kit and Master Mix 
(Invitrogen), following manufacturer’s instructions. Controls with no Superscript enzyme 
were performed in parallel and cDNA was analysed with RT-PCR, using primers indicated 
in table 4. 
 
2.2.4 - Interphase frog egg extract preparation 
From Xenopus eggs is possible to isolate a clear cytosol, which contains both soluble 
proteins of the disassembled nuclei as well as soluble cytoplasmic proteins.  
Xenopus eggs are isolated from hormonally primed female frogs. Eggs are arrested in 
interphase with cycloheximide, which, acting at the ribosome level, prevents new protein 
synthesis. In particular Cyclin B in not synthetized and mitosis is inhibited.  
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Collected eggs are treated with Dejellying Buffer to remove the gelatinous coat around the 
eggs and washed three times with MMR wash buffer, by swirling gently and pouring out 
the wash buffer. Eggs are then activated for 5’ with calcium ionophore at 1 µg/ml, which 
leads the exit from M phase and re-entry into interphase, to have a synchronous activated 
eggs extract. Eggs are washed three times with MMR wash buffer and 3 times with ice-
cold S-buffer (supplemented with Leupeptin 15 µl/mL) for lysis and to stop activation. 
Packed eggs are then centrifuged at 13200 rpm for 12’ at 4 °C. Eggs will separate into 
three different layers: a top bright yellow layer that contains lipids, a middle golden layer 
containing cytoplasm and membranes and a bottom dark layer containing pigment and 
yolk granules. Cytoplasmic fraction is collected with a small Pasteur pipette and 
cytochalasin B (4 µg/mL) is added in order to prevent actin polymerization and to 
dissociate the membranes. The fraction is then transferred in ultracentrifuge tubes 
(Beckman 349622) and centrifuged at 70000 rpm 12’ at 4 °C (TLA100.3 rotor). 
Membranes and cytosol are separated from the bottom mitochondria layer, which is 
discarded. Cyclohexemide (40µg/mL) is added to inhibit protein synthesis and ATP (30 
mM creatin phosphate and 150 µg of creatin phosphor kinase are added to have a 
nuclear competent extract). With 5 % glycerol addition FE is frozen drop wise in LN.  
 
Genomic DNA extraction 
DT40 CL18- cell pellet was washed in PBS 1x and resuspended in Lysis Buffer (with SDS 
and Proteinase K). After 2h at 56 °C phenol/chloroform extraction was performed. 
Residual phenol was removed with 2 volumes of diethyl ether and DNA was precipitated 
with 2 volumes of isopropanol and 750 µl of cold 70 % ethanol. DNA was resuspended in 
10 mM Tris-HCl pH 8. 
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2.2.5 - Cloning methods  
 
General PCR 
PCR from chicken genomic DNA was performed in a total volume of 25 µl. 50 ng of DNA 
were amplified in a reaction buffer composed of 1x Pfu Buffer, 0.2 mM dNTPs, 0.4 pMol / 
µL of primers and 1.25 Units of Pfu polymerase. The amplification program was as follow: 
94 °C for 30”, 10 cycles of 94 °C for 30”, decreasing touchdown from 65 °C by 1 °C every 
cycle and 72 °C for 2’. Then 25 cycles at 94 °C for 30”, gradient from 58 °C to 68 °C for 1’ 
and 72 °C for 2’ was applied. PCR was carried out using an Eppendorf Mastercycler 
gradient PCR machine.  
PCR Gel purification 
PCR products were loaded onto agarose gels and after electrophoresis bands were 
excised and purified with QIAquick gel extraction kit (Qiagen), accordingly to the 
manufacturer’s instructions. Elution from columns was performed in 50 µL of TE buffer.  
Topo TA Cloning 
PCR fragments were cloned into TOPO vector using the TOPO TA Kit dual cloning 
promoter (Invitrogen), according to manufacturer’s protocol. Transformed E. coli cells 
were plated on LB agar plates with ampicillin (50 µL of 50 mg/mL) and X-gal (80 µL of 20 
mg/mL) and grown at 37 °C overnight.  
Colony PCR  
A single bacterial colony was resuspended in 100 µL of LB medium. 1 µl of a 1:100 
dilution of the bacterial suspension was added to a 24 µL PCR reaction that included the 
primers, 2.5 µl of 10x Taq buffer, dNTPs at 0.4 pMol/µL and 1.25 Units of Go Taq 
polymerase (Promega). The reaction was initially denatured at 95 ºC for 30”, followed by 
10 cycles of denaturation at 94 ºC for 30”, annealing at 55 ºC for 30”, extension at 72 ºC 
for 30” before a final extension at 72 ºC for 52’ to generate the PCR product. The acquired 
PCR product was run on a 1 % agarose gel for verification purposes. 
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Fragment Preparation 
Samples were prepared in a total reaction volume of 30 µL by mixing 1 µg of DNA with 
NEB buffer compatible with the enzyme used and 10 Units of restriction enzyme. Samples 
were then incubated at the recommended temperature for 2h. After incubation the 
enzymes were heat inactivated and the DNA was treated with 5 Units of Alkaline 
Phosphatase (CIP, Neb) at 37 °C for 1h. Digested fragments were purified on agarose 
gels.  
DNA Ligation 
Ligation reaction was performed in 20 µL by mixing 2 µL of 10x T4 DNA ligase Buffer, 
approximately 30 ng of digested vector backbone and DNA insert in molar excess of 3-10 
times compared to backbone. 400 Units of T4 DNA ligase (NEB) were added to the 
reaction and samples were incubated for 1h at RT. 
Competent cells preparation 
C41 cells, E.Coli cells derived from BL21(DE3) strain, were freshly plated onto a LB plate 
and grown ON at 37 °C. A single colony was inoculated in a 3 mL starter culture of 2xTY. 
After 1h at 37 °C the culture was diluted to 100mL with fresh 2xTY and grown until OD600 
reached 0.35. Cultures were then cooled down in ice cold water for 20’. Cells were 
harvested by centrifugation at 4000 rpm for 15’ at 4 °C. Pellet was washed with 10 mL of 
icecold 100 mM MgCl2 and cells were collected by centrifugation at 3000 rpm for 15’. 
Cells were resuspended in 20 mL of 100 mM CaCl2 and left on ice for at least 20’. After 
final centrifugation at 2100 rpm for 15’, cells were resuspended in 200 µL of ice cold 100 
mM CaCl2 and were ready for transformation. 
Bacterial transformation 
E. coli cells were transformed with pGL4.31 as follow: 10 ng of plasmid were gently mixed 
with 50 µL of Subcloning Efficiency™ DH5α™ Competent Cells (Invitrogen). Bacteria 
were incubated on ice for 20’ before heat shock at 42 °C for 20” and subsequent cold 
shock for 2’ on ice. Bacteria were incubated at 37 °C 1h with 900 µL of S.O.C. warm 
medium. 200 µL of the culture suspension was plated in amp/LB plates and incubated at 
37 °C O.N. When C41 fresh competent cells were used for transformation (with pSPM589 
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and pDMF1620 plasmids), bacteria were mixed with plasmid DNA and incubated on ice 
20’ before heat shock at 42 °C for 2’. After growth at 37 °C 1h bacteria were plated on 
kan/LB plates. One Shot® TOP10 Chemically Competent E. coli (Invitrogen) were 
transformed with pEI7150 and pEI7151 plasmids following manufacturer’s instructions.  
Mini and Maxi-preparation of plasmid DNA 
3 ml of LB medium with antibiotics in a 5 ml polystyrene round-bottom tube (BD 
FalconTM) was inoculated with a single transformed E. coli colony. The culture was 
incubated overnight, shaking at 37 ºC. For Mini-preparation 2 ml of bacteria culture was 
harvested by centrifugation at 10,000 rpm for 3’. Isolation of plasmid DNA was then 
carried out using Wizard Plus SV Miniprep DNA purification system (Promega) according 
to the manufacturer’s instructions. DNA Mini preparation of pGL4.31 was performed with 
the same kit at 4 °C to maximize supercoiled plasmid elution (160).  
For Maxi-preparation 2 mL of bacteria culture was diluted in 200 mL LB medium and 
grown for 12-16 h at 37 °C shaking. Bacterial cells were harvested by centrifugation at 
6,000 x g in a Beckam JA-14 rotor for 15’ at 4 ºC and DNA was purified using QIAGEN 
Plasmid Maxi Kit (Qiagen) according to the manufacturer’s instructions. 
DNA Sequencing 
DNA sequencing reaction was performed by Cogentech sequencing unit.  
 
2.2.6 - G-AID expression and purification 
Recombinant GAL4-AID, wild-type (WT) and mutant (Mt), were expressed and purified 
from E. coli C41 cells. Cells were transformed with pSPM589 and pDMF1620 (described 
in Figure 9), were grown until they reached OD600=0.6. GAL4-AID expression was 
induced by addition of 0.4 mM IPTG in the presence of 10 µM ZnCl2 for 14 h at 16  °C. 
After the overnight culture, the bacterial pellet was washed in ice cold water and 
resuspended in 20 mL (per 1 L of culture) of extraction buffer. The cell lysate 
corresponding to 1 L culture was sonicated for 12’, duty cycle 5 in a Branson sonicator, at 
maximum power. The sonicated suspension was centrifuged at 165,000 g for 90’ at 4 °C, 
and the supernatant was collected and filtered in a 0.2 µm filtering device. The protein 
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solution was then incubated with 0.5 mL (per 1 L of culture) of Talon Metal affinity resin 
(slurry, 50 %) (Clontech) for 90’ at 4 °C. The resin was washed in Bio-Rad Gravity 
columns (Bio-Rad) by addign 5x bed volumes of extraction buffer and proteins were 
eluted in 2.5x bed volumes of extraction buffer containing 200 mM imidazole. After elution, 
proteins were concentrated in VIVASPIN 500 columns (Sartorius), with a Molecular 
Weight Cut-Off (MWCO) of 10,000 Daltons (as GAL4-AID is 45,000 Daltons).  
 
2.2.7 - Western Blot 
Protein samples were mixed with laemmli Buffer to a final concentration of 1x laemmli, 
denatured at 95 °C for 5’ and loaded on a 12.5 % Poly-Acrylamide gel. Electrophoresis 
was performed for 90’ at 120 Volts in Running Buffer. After electrophoresis, proteins were 
transferred from the gel to a PVDF membrane (Westran 0.2 µm) for 2 h in Transfer Buffer 
at 100 V at 4 °C. After the wet transfer, the membrane was blocked with 5 % milk in TBST 
for 1 h at RT to saturate the non-protein containing areas and to prevent unspecific 
binding of the antibodies. Once the membrane was blocked, it was incubated with specific 
antibody (indicated in table 5) 2h at RT. After 3 washes for 10’ in 1x TBST vigorously 
shaking, the membrane was incubated with the specific secondary antibody for 45’ at RT. 
After 3 washes in 1x TBST, signals were detected with ECL Luminata at ChemiDoc™ MP 
System (Bio-Rad).  
 
2.2.8 - Coomassie  
Protein samples were mixed with laemmli buffer to a final concentration of 1x laemmli, 
denatured at 95 °C for 5’ and loaded on a 12.5 % Poly-Acrylamide gel. Electrophoresis 
was performed for 90’ at 120 Volts in Running Buffer. To visualize protein in Poly-
Acrylamide gels, coomassie Brilliant Blue Staining was performed. The gel was incubated 
with coomassie Brilliant Blue Staining Solution for 4 h to ON at RT upon mild agitation. 
Gel was destained in De-staining Solution, which was exchanged until the excess dye 
was removed from the gel. Images were collected using the ChemiDoc™ MP System 
(Bio-Rad). 
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2.2.9 - Gel mobility assay 
300 ng of plasmid DNA was either mixed with water (untreated) or treated with GAL4-AID 
or with restriction enzymes and incubated for 30’ at 37 °C. After treatment, to stop the 
reaction and to digest added enzymes 15 µl of lysis buffer were added and incubation was 
performed at 56 °C for 2 h. The topology of the plasmid was then assayed on a 0.8 % 
agarose gel. After allowing migration of the DNA at 5–10 V/cm for 16 h at 4 °C the gel was 
soaked in 1x TBE containing SYBRH Safe DNA gel stain (Invitrogen) for 30’. Plasmids 
were visualised by analysing the gen with a ChemiDoc™ MP System (Bio-Rad). 
 
2.2.10 – Rifampicin assay 
BW310 E.Coli strain (lacking UNG) were transformed with plasmids pDS4501 and 
pSPM589 (expressing G-AID). Plates were grown at 37 °C for 16-18h. 8 clones per 
transformant (with same dimension) were collected and diluted in 1.5 ml of 2xTY in 96 
well dish. After vortexing the plate for 5 min at 1300 rpm, from each 1.5 mL of culture 1 µL 
was transferred and diluted 1:1000 in 1.5 ml of 2xYT, supplemented with the inducing 
factor (0.3 mM IPTG), the co-factor for AID activity (10 µM ZnCl2) and the specific 
antibiotic for selection (100 µg/ml carbencillin). Cultures were grown O.N at 37 °C upon 
constant vortexing at 1300 rpm. For putative mutation observation 200 µL of randomly 
chosen 8 cultures of each transformation were plated onto rifampicin LB plates. For a 
preparation of 150 rifampicin plates 0.4 g of rifampicin was dissolved in 9 ml DMSO and 
added to 5 liters of LOW salt LB. Plates containing rifampicin were protected from light 
during storage. For viability observation 6 cultures of each transformation were diluted 
1/106 and 50 µl of each diluted culture were plated on ampicillin LB plates. The frequency 
of deamination affects the number of cells acquiring resistance. Mutation frequency was 
determined by counting the number of rifampicin resistant colonies vs the number of 
viable colonies.  
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2.2.11 - ssDNA oligonucleotide deamination assay  
The GAL4-AID ssDNA oligonucleotide deamination assay was performed as follows: 2.5 
pmol of the biotin-tagged and fluorescein-tagged oligonucleotide 163 (table 4) was mixed 
with 10 µg of RNase A in 10 µl reaction buffer R, denatured for 3’ at 90 °C. Reaction were 
stopped by transferring tubes in ice-water. Oligonucleotides were incubated for 15’ at 37 
°C with 10 - 50 ng of recombinant protein. Reactions were stopped by addition of 100 µl of 
H2O. 8 µl of streptavidin magnetic beads (Dynal M270, Invitrogen) were added to 1 mL of 
TE-1000 and incubated with the oligonucleotides for 15’. Beads were collected, washed 
twice in TE-1000 preheated to 70 °C, once in TE at RT, and resuspended in Uracil-DNA 
Glycosylase (UDG, New England Biolabs) reaction mix, prepared according to 
manufacturer protocol, and incubated for 1 h at 37 °C. Cleavage reactions were stopped 
by addition of 20 µl 0.4 % fushin in formamide and denaturation at 90 °C for 3’. After 
quenching on ice, samples were resolved on 17.5 % TBE PAGE urea gels at 200 V and 
visualised using a Typhoon scanner (GE Healthcare) for fluorescence imaging (Filter: 526 
SP (532 nm), Laser: Blue 488 nm). 
 
2.2.12 - dsDNA oligonucleotide DNA glycosylases assay  
The ds DNA oligonucleotide glycosylases assay was performed with oligonucleotides 164 
and 166 (table 4). The oligonucleotides were mixed in 50 mM NaCl, Tris-HCl pH 8.0, 
denatured for 5’ at 90 °C, and annealed by slowly cooling to RT (30’). ds oligonucleotides 
(containing the mismatch dU:dG) were purified using streptavidin magnetic beads and 
incubated with cellular extracts for 15’ at 37 °C. To enhance strand cleavage NaOH (0.3 
M) was added. Samples were analysed as above. To inhibit UNG activity present in the 
cell extracts UGI was added to the extracts 10’ (on ice) prior to the incubation with the 
oligonucleotides. Samples were resolved 17.5 % TBEPAGE urea gels as previously 
described. 
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2.2.13 - In vitro resolution assay (IVR) 
The ‘in vitro resolution assay’ (IVR) was developed in the Petersen-Mahrt laboratory (159) 
to quantify GAL4-AID activity and repair achieved upon recruitment of DNA repair 
proteins. IVR can be divided into two main reactions: 
1) Deamination reaction: 300 ng of supercoiled pGL4.31, 10 - 50 ng of GAL4-AID were 
mixed in IVR buffer 1X and incubated for 30’ at 37 °C. During this phase, GAL4-AID can 
deaminate pGL4.31. 
2) Repair reaction: 0 to 40 µg of cellular extract was added to the deamination mix in the 
presence of 0.2 µg/µl aphidicolin, 0.05 mM dNTP-bioC (without dCTP and 0.05 mM 
biotinylated-dCTP (Invitrogen) or 0.05 mM dNTP-A (without dATP and 0.05 mM 
biotinylated-dATP (Invitrogen), and incubated for 30’ at 37 °C. When specified, UNG 
inhibitor (UGI - New England Biolabs) or PCNA inhibitor T2AA (T2AA is the inhibitor of the 
PIPbox peptide/PCNA interaction – (161)) were added to the extracts for 10’ on ice prior 
to the addition to the repair reaction.  
After the repair reaction, free Bio-dNTPs were removed with the Qiaquick PCR purification 
kit (Qiagen) and plasmids were eluted in 100 µl of elution buffer. From this eluate 2 µl 
(further diluted 10 fold) was used as ‘input’. The remaining eluted plasmid was subjected 
to Dynabeads M-270 streptavidin magnetic bead (Invitrogen) purification in TE – 1000. 
Mixtures were gently rotated for 15’ at RT and beads were collected by incubation for 2’ 
on a DynaMag-2 magnet (Invitrogen). The following washes of the beads were applied: 
TE – 500 at RT, TE – 100 at 65 °C, TE – 50 at 65 °C and TE -0 at RT. Beads were finally 
resuspended in 100 ml TE (without Tween-20) and subjected to quantitative real-time 
PCR.  
 
2.2.14 - RT-PCR and statistical analysis  
The RT-PCR reaction was performed in a final volume of 10 µl, containing 2 µl of the 
bound DNA bead mixture, 5 µl of the LightCycler 480 SYBR Green I master (Roche 
Applied Sciences) and specific primers (table 4). The reaction was monitored in a 
LightCycler 480 Real-Time PCR System (Roche Applied Sciences); with the ‘input’ DNA 
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analysed in parallel as reference. Ct values for the biotinylated-DNA were correlated to 
the Ct values for the input DNA. The IVR results were presented either as relative 
quantification (fold-change) or absolute (% of input). For fold-change, all samples were 
compared to their input (defined as the plasmid DNA that was present in the reaction prior 
to the streptavidin isolation) and then the FE alone sample (or another samples specified) 
was used as reference and set to one. The fold change was calculated according to the 
ΔΔ-Ct algorithm, represented as: Fold Change = 2{-[(Xo-Xi)-(Ro-Ri)]}, where X - sample; R - 
reference extract alone; o - output (post bead isolation); i - input (pre-bead isolation). 
Alternatively, in the % of input analysis the Ct qPCR values of input and output were 
converted to an absolute amount of DNA based on a standard curve (performed in 
parallel to the analysis), with the amount of isolated biotinylated-plasmid being expressed 
as a percentage of the initial amount of plasmid (input). 
 
2.2.15 - Atomic Force Microscopy 
Atomic Force Microscope (AFM) was used to image single molecules at nanoscale level, 
with high resolution. The heart of the AFM is the cantilever, a plate spring fixed at one 
end; while at the other end it supports a sharp tip. The pointed tip is brought into contact 
with the sample and moved across the sample surface line by line (Figure 9A). AFM 
images are obtained by measurement of the force created between a sharp tip and the 
surface of the sample (162). In particular, attractive or repulsive forces between the 
sample and the tip are converted into a deflection of the cantilever, which is detected by a 
laser beam reflection from the back of the cantilever onto a photodetector (Figure 9A). 
Deflection of the cantilever results in a change of the laser reflection angle and a change 
in the voltage signal.  
AFM visualization was initially performed in collaboration with Alessandro Podestà, 
Università degli studi di Milano using a Bruker Nanoscope. Further images are obtained 
from JPK Nanowizard 3 AFM at IFOM. Using a tapping mode (Bruker) or AC mode (JPK) 
the tip was intermittently contacting the surface with constant oscillation, without being 
trapped by adhesive forces coming from sample (Figure 9B).	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Figure 9 – Drawing of basic principles of Atomic Force Microscopy (AFM).  
A) A cantilever, with a very small tip (or probe), moves along the surface and experiences atomic 
forces. The tip is on the end of a cantilever, which deflects when the tip encounters features on 
the sample surface. An optical laser beam senses this deflection. The end of the cantilever is 
reflecting the laser onto a segmented photodiode that magnifies small cantilever deflections into 
large changes in the relative intensity of the laser light. B) AFM imaging in contact mode the tip 
continuously sense the sample surface; soft samples can thus been damaged or distorted. AFM 
imaging in tapping mode or AC mode minimizes this problem by having the tip oscillate over the 
sample, making only brief intermittent contacts. This mode also provides additional information 
about the sample surface that corresponds to the height image. 
 
AFM samples preparation 
DNA was diluted in mM MgCl2 and 10 mM HEPES or in 1 mM NiCl2 and 10 mM HEPES. 
the standard concentration of DNA used was 1 ng/µl. 20 µL of the DNA solution was 
applied on the MICA surface, incubated for 5’ and MICA surface was washed with 3x with 
500 mL of MilliQ grade H2O. Finally the MICA was dried with N2 flow for 5’, with and angle 
of 75 ° relative to the MICA. After DNA deposition, proteins were added to DNA, in the 
same buffer. MICA disc was washed and dried as before.  
When the MICA disc was coated with poly-L-ornithine (SIGMA) to create a positive 
surface for DNA binding, 20 µL of a 0.01 % poly-L-ornithine solution was spread on the 
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MICA surface. After 5’ incubation the MICA surface was washed three times with MilliQ 
grade H2O. 
 
2.2.15.1 - In Vitro nucleosome reconstitution  
160 fmols of DNA were incubated with different concentrations of recombinant human 
histone octamer (Tebu-Bio S.R.L.) (0 to 280 fmols) in 20 µL of 2M NaCl buffer for 30 min 
at RT. A subsequent dialysis reaction was performed reducing the NaCl concentration 
from 2M to 1M (2h at RT), to 0.65M (2h at RT) to 0.2M (O.N at 4 °C). The final solution 
(fully reconstituted nucleosomes) in 0.2 M NaCl buffer was loaded onto MICA 
polyornithine coated surface and imaged in AC mode in AFM.  
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CHAPTER 3 - RESULTS 
 
3.1 - DEVELOPMENT AND VALIDATION OF A NEW BIOCHEMICAL ASSAY TO 
STUDY G-AID INDUCED LESIONS RESOLUTION IN FROG EGG EXTRACT (FE) 
 
Previous work in our lab defined the biochemical characterisation of in vitro AID enzymatic 
activity (119). Those results provided the kinetics of AID-induced lesion generation, but 
less was known about the extent of DNA repair of those uracils. We decided to use the 
characterized AID damaging agent as a tool to determine the contribution of various DNA 
repair pathways to lesion resolution in a physiological context. 
A new biochemical assay, named in vitro resolution (IVR) was designed to investigate the 
molecular mechanisms of damage resolution. The method is composed of two phases: 1), 
AID was targeted to a ssDNA substrate and 2) a cell extract was used to repair the AID-
induced lesions (Figure 10 and (159)). To target AID to a DNA substrate in vitro, a fusion 
protein was generated. A bacterial expression vector (pSPM589) was cloned fusing the 
cDNA sequence for human AID (AID) to the DNA binding domain of GAL4 (G) generating 
G-AID. G-AID is targeted to a supercoiled (SC) plasmid harbouring the GAL4 binding sites 
(UAS). The SC topology of the plasmid provides both the dsDNA for GAL4 binding and 
the ssDNA required for AID activity. After G-AID creates dU lesions, in the second phase 
of IVR the lesions are repaired by cell extracts competent for DNA repair. To establish the 
IVR, we utilised Xenopus leavis egg extract (FE). This type of extract has been used in 
the past as a model extract to study the control of cell cycle progression, apoptosis, 
nuclear formation, nucleocytoplasmic transport, spindle microtubule dynamics, chromatin 
structure, and importantly DNA repair (163). DNA topoisomerases in the FE relax the 
plasmid forming a dU:dG mismatch, providing a substrate for multiple DNA repair 
pathways. During repair of the uracil lesion a biotinylated-dCTP (bio-dC) can be 
incorporated into the plasmid, providing a tag for isolation and quantification. Importantly, 
DNA repair pathways that excise several bases surrounding the lesion can also 
incorporate other dNTPs; hence addition of biotinylated-dATP (bio-dA) can be used to 
RESULTS 
	   	  	  	   64 
identify specific DNA repair pathways subtypes. Biotinylated plasmids are isolated via 
streptavidin beads, and the amount of deaminated and repaired plasmid is determined by 
quantitative real-time PCR. Ct values for the biotinylated-DNA were correlated to the Ct 
values for the input DNA (total plasmids prior to bead isolation). IVR results can be 
represented as relative (fold change) or absolute (% of input) quantifications. 
   
Figure 10 – Schematic representation of the IVR assay 
The supercoiled pGL4.31 (containing 5x UAS sequences for GAL4 binding) was incubated with 
G-AID protein (yellow triangle and red circle). During incubation at 37°C for 30 min G-AID 
randomly deaminated dC creating dU lesions in ssDNA (green star). The repair phase (yellow 
box) was carried out by the addition of FE in the presence of biotinylated dCTP (bio-dC) or 
biotinylated dATP (bio-dA) - (blue arrow), along with normal dNTPs. After DNA repair of the dU 
lesion the biotinylated-tagged DNA was isolated via magnetic streptavidin beads. Deaminated 
and repaired plasmids were analysed through quantitative real-time PCR (red bar), and 
compared to input values (total amount of plasmids not streptavidin isolated). 
© Franchini et al, 2013, PLoS ONE
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3.2 - VALIDATION OF THE IVR ASSAY IN FE 
 
IVR is a sensitive method; we ensured that DNA lesions occurring during IVR were 
exclusively due to G-AID induced uracils. Each component used in IVR assay was 
evaluated for non-specific DNA damaging activity. In particular, we checked G-AID protein 
after purification form E. coli and if the extracts were retaining nicking activity. As a 
control, to ensure G-AID catalytic activity was the only requirement needed to activate 
repair mechanisms, a G-AID mutant protein (G-AID mt) was purified at the same time. 
The catalytic mutant was generated by substituting the negative charged glutamic acid 
(E58) in the active site of hAID with a glutamine (Q58) (pDMF1620). This mutant is unable 
to provide the required proton donor in the active site (164) 
To validate the assay we checked: 1) G-AID purity with Western blot and coomassie, 2) 
G-AID nicking activity on SC plasmids, 3) G-AID catalytic activity and 4) extracts nicking 
activity on SC plasmids. 
 
3.2.1 - G-AID protein production optimization leads to the purification of an 
endonuclease free protein 
 
In order to study DNA lesion generation and resolution of the DNA damaging protein AID 
in vitro, we needed to isolate AID from E. coli. The His-tagged G-AID fusion proteins were 
isolated from bacteria lysates using TALON beads. Eluates were quantified and analysed 
for the presence of co-purified contaminant proteins (Figure 11). Full length G-AID (FL G-
AID) and two break-down products, due to sensitivity to proteolytic cleavage between 
GAL4 and AID, were visible both in Western blot (Figure 11A – arrows) and coomassie 
analysis (Figure 11B - arrows). Quantitative analysis revealed that 280 ng/µL of FL G-AID 
were purified (Figure 11C); in total 28 µg of pure FL protein were extracted from 2 L of 
bacterial culture. However, coomassie analysis revealed additional bands (Figure 11B). 
Through a mass spectrometry approach, proteins associated with AID (purified from E. 
coli with the same approach used for G-AID) were identified as 60 kDa chaperonin (or 
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GroEL), elongation factors, and ribosomal units required for prokaryotic translation (data 
not published – Gopinath Rangam). The more prominent band in coomassie can be 
identified as GroEL.  
 
Figure 11 – Quantitative and qualitative analysis of G-AID purified protein 
A) G-AID protein is detected with anti-His antibody. 0.5 and 0.05 µL of concentrated protein were 
loaded on the gel. FL protein is visible both in Western Blot and in coomassie analysis (red 
arrow). Two other specific products are recognized by anti-His antibody and correspond to 
breakdown products (green and blue arrows). B) In the coomassie staining additional bands 
appeared. Based on previous experiments, the more prominent band at 60 kDa was identified as 
the 60 kDa chaperonin. C) FL protein (red) and breakdown products (green and blue) were 
characterized for dimension and quantified. FL protein harbour human AID fused to the DNA 
binding domain of GAL4 (GAL4). Additional tags are: protein C tag (P), TEV sequence to cut off 
tags to the protein (T), Flag tag (F) and His-tag (H). FL protein is 42kDa and was quantified from 
coomassie gel using BSA as standard. FL protein is 280 ng/µL.  
 
To analyse whether the co-purified factors exhibit potential nuclease activity that could 
interfere with the IVR assays, the G-AID eluate was incubated with supercoiled pGL4.31, 
a plasmid containing 5x G-DNA-binding sites (UAS). Topology and integrity of the plasmid 
were monitored with a gel mobility assay (Figure 12). The untreated plasmid displayed 
three topological isoform: concatenated, nicked (or open circular) and supercoiled (Figure 
12 - (-) samples). When plasmids were incubated for 30 min with G-AID, topology was 
unvaried with the exception of a faint linearized band, due to contaminant nuclease 
activity (Figure 12A - green arrow). To separate G-AID from co-purified nucleases, the 
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eluate was fractionated and evaluated for linearization (Figure 12B). DSBs appeared only 
when plasmids were incubated with the first eluate fraction (Figure 12B - orange arrow), 
indicating that nucleases elute early from the TALON beads. In all subsequent G-AID 
preparations the first eluate fraction was excluded from the final concentrated product. 
After this optimization G-AID WT and G-AID mt proteins displayed the same topological 
profile as the mock-incubated plasmid, with no nucleases contamination (Figure 12C). To 
maximize the SC topology, needed for the IVR assay, the plasmid isolation was 
performed at 4°C (160). Under this condition more than 90 % of the plasmids were in SC 
conformation (Figure 12C). 
 
Figure 12 – DNA topology following G-AID induced-damage 
A) Various forms of pGL4.31 were analysed on a 0.8 % agarose gel run at 5 – 10 V/cm for 16 h 
at 4°C. Supercoiled DNA (SC) migrated faster than linear (L – 6 kb, digested 2h at 37°C with 
BamH1), while nicked/open circular (N/Oc – digested 2h at 65°C with Nb BsmA1) or 
concatenated DNA (Co) migrated slowest. When G-AID was incubated with the plasmid a faint 
linear band appeared (green arrow). B) Different elution fractions of G-AID (lane 1 to 7) were 
incubated with pGL4.31 and analysed on agarose gel: in lane 1 linear DNA was visible (orange 
arrow). C) G-AID WT or mt concentrated proteins (without the first elution fraction) were 
incubated with pGL4.31 and analysed on agarose gel. % of plasmid topologies (calculated with 
Chemidoc™ Image Lab™ Software) are indicated in the Figure.  
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3.2.2 - G-AID protein retains its catalytic activity 
 
In order to use G-AID as a natural DNA mutator, we checked its activity both in vivo and in 
vitro. E. coli cells lacking UNG activity (BW310 strain) and thus unable to repair AID 
lesions, were transformed with an expression vector containing either AID or G-AID cDNA 
(pDS4501 or pSPM589, respectively). After induction of protein expression, only cells 
harbouring a deaminated and mutated genome can acquire resistance to rifampicin 
antibiotic. Mutation frequency is a direct measure of AID deamination activity and was 
determined by establishing the number of resistant colonies versus the viable colonies 
(165). As expected, AID was able to mutate E. coli genome, compared to cells transfected 
with a mock plasmid (pETduet). G-AID, despite the structural implication of the fusion of 
AID with GAL4, displayed mutagenic activity in vivo, reduced only by 2.5 fold compared to 
the unmodified protein (Figure 13A).  
 
 
Figure 13 - G-AID deaminates cytosine to uracil in E. coli and in vitro 
A) E. coli strain UNG deficient (BW310) was transformed with AID or G-AID expressing plasmid 
(pDS4501 or pSPM589, respectively) and pETduet as control. Median number of colonies grown 
on rifampicin was divided by average number of colonies grown on ampicillin plates. Results from 
E. coli transformed with pETduet were set to 1. B) ssDNA oligonucleotide deamination assay was 
performed using a 40mer oligonucleotide (spm163) containing a single cytosine. Two 
concentrations (20 ng and 200 ng) of G-AID and G-AID mt, as well as untagged AID (200 ng) and 
BSA (1 µg) were incubated with 2.5 pmols of oligonucleotides for 30 min at 37°C. Image-J 
program was used to calculate bands relative area and density. Further calculations were 
performed to remove background specific for each single band. % of conversion was calculated 
as: intensity lower band*100/[intensity upper band + intensity lower band]. 40 % of the 
oligonucleotides were deaminated by AID, while G-AID displayed activity versus 20 % of the 
substrates. 
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The E. coli results were confirmed in vitro with a ssDNA oligonucleotide deamination 
assay (165). Only if AID deaminates the dC in the WRC motif is UNG able to remove the 
lesion and APE or NaOH to cleave the oligo. Hence, oligo cleavage is proportional to 
deamination activity. From the assay it is clear than G-AID WT retained the deamination 
activity in vitro, while G-AID mt was not catalytically active (Figure 13B). The % of 
conversion confirmed the E. coli results: G-AID was roughly 2 fold less active than AID.  
 
3.2.3 - G-AID-independent DNA repair activation is excluded from IVR readout 
 
After confirming that G-AID is not contaminated by nucleases and retains its catalytic 
activity, we checked whether G-AID activity is the only factor able to induce DNA repair 
activation and hence bio-dC incorporation. Xenopus cell-free extracts support efficient 
DNA replication of added DNA substrates (166,167). In the IVR system, replicative DNA 
polymerases could induce replication of the SC plasmid and hence bio-dC incorporation 
independently from AID-induced damaged. Replication was inhibited by aphidicolin in the 
extract, and is added before the repair phase. Indeed, in the presence of aphidicolin the 
number of plasmids incorporating bio-dC was reduced by over 40 fold (Figure 14). Unless 
indicated, subsequent IVR experiments were performed in presence of aphidicolin to 
exclude DNA repair independent incorporation of bio-dC.  
 
Figure 14 – Quantification of FE replication dependent repair 
IVR was performed without G-AID protein. Repair was performed by FE (with bio-dC) in the 
presence or absence of aphidicolin. Samples treated with aphidicolin were set to one. Aphidicolin 
treatment reduced the IVR by 40 fold. Error bars indicate SD (n = 3). Time line of experiment is 
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shown next to the graph. Statistical analysis (t-test) was performed on differences of indicated 
fold increase. * p value is indicated in the figure. 
Plasmid integrity was also monitored as SSBs or DSBs generation can lead to DNA repair 
activation (AID independent). Indeed, when nicking enzymes were used to create a 
damaged plasmid, a 4-fold increase in repair was registered, compared to non-treated 
plasmid (Figure 15). When SSBs were sealed by addition of T4DNA ligase, repair 
pathways activation was reduced to the levels of the unmodified substrate (Figure 15), 
indicating that the 4-fold increase was exclusively dependent on nicking activity.  
 
Figure 15 – Quantification of SSBR in FE 
IVR was performed using a modified substrate. Plasmids were either digested or not with AlwI 
nicking enzyme. After enzyme heat inactivation, plasmid was treated or not with T4DNA ligase. 
Purified plasmids were then repaired by FE (with bio-dC) in the presence of aphidicolin. Results 
from untreated plasmids were set to one. Nicking treatment increased the IVR by 4 fold. Time line 
of experiment is shown next to the graph. 
 
Integrity of the plasmid was checked also with gel mobility assay (Figure 12C). 
Quantification of the ratios between supercoiled, nicked, and concatenated plasmids 
topologies showed that optimal G-AID preparation did not impact original plasmid topology 
(Figure 12C). 
 
3.3 – KINETIC PROFILES OF AID-INDUCED DAMAGE AND FE DEPENDENT REPAIR  
 
Once we could control the IVR readout, we performed the assay in the presence of G-AID 
and different controls (Figure 16). Only when G-AID was incubated with SC plasmid and 
then added to FE could we detect a significant biotinylation of plasmid. Using only the 
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GAL4-DNA binding domain (G-DBD) or the catalytic mutant of G-AID we did not induce 
any bio-dC incorporation, indicating that AID catalytic activity is required to initiate DNA 
damage and resolution in the FE. Interestingly, when untagged AID was used in IVR, less 
DNA repair was observed compared to G-AID, while from in vitro oligonucleotide assay 
AID was more active than G-AID (Figure 13B). GAL4 binding domain helped AID activity 
on the SC substrate during IVR assay. 
 
 
Figure 16 – AID-induced lesions repair in FE 
AID-induced lesions are repaired in FE. SC plasmids were treated (or not - bar 1) with the G-AID 
WT or mt proteins (the mutant used in this assay is C87R (164)) and then incubated in FE (or not 
- bar 2), isolated, and quantified by qPCR. The blue bars represent the ratio (fold change) of the 
amount of recovered plasmids from reactions carried out in the presence of G-AID (bar 3), 
untagged AID (AID; bar 4), GAL4 DNA binding domain (G-DBD; bar 5), or mutant G-AID C87R 
(G-AID mt; bar 6) versus levels of plasmids recovered from reactions that did not contain G-AID 
(FE alone, set to 1; bar 1). Pink bars represent the absolute recovery of each treated sample in 
relation to its input. Error bars indicate SD (n = 3). Statistical analysis (t-test) was performed on 
differences of indicated fold change (brackets), with p values shown. Time line of the experiment 
is shown above the graph. 
 
Once the IVR system relied on G-AID induced DNA repair activity only, we optimized the 
concentration of G-AID protein and the concentration of FE to maximize their efficiency 
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(Figure 17). Different concentrations of G-AID WT or mt were used in the IVR assay to 
establish the kinetic profile of DNA damage-induced repair activation (Figure 17A-B). In 
Figure 17A, both G-AID WT (filled bars) and G-AID mt (empty bars) results are shown, to 
empathize that at higher concentration G-AID mt is not able to initiate DNA lesions and to 
provide a visual record to the background activity of the IVR system. In Figure 17B and in 
all subsequent results G-AID mt readout was subtracted from G-AID WT results. 
Moreover, we can demonstrate that repair proteins are responsible for IVR readout by 
using UGI, a small phage peptide known to specifically inhibit UNG enzymes (168). Since 
UNG is a DNA glycosylase able to recognize uracil in DNA and activate BER pathway 
(29), its inhibition should result in a reduction in repair activation upon AID-damage. 
Indeed, when UGI was added to FE activity was reduced by 56 % to 88 % (depending on 
G-AID concentration) (Figure 17B). 
Using the concentration of G-AID that gives maximum IVR activity (0.66 pmols – Figure 
17B), we performed FE titration (Figure 17C-D). After a linear increase in activity with 
increasing amount of FE, 50 µg of extract were less efficient. While using even higher 
concentrations of FE, we detected again a linear correlation until it plateaued-out near 200 
µg (Figure 17C). We did not pursue this observation, and hypothesised that this trend 
could be the result of the interplay between two different repair pathways, whose 
activation may require a threshold amount of active repair protein.  
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Figure 17 – G-AID and FE titration in IVR assay  
A) SC plasmids were treated with increasing concentrations of G-AID WT (filled bars) or G-AID 
mt (empty bars) and then incubated with FE, in the presence of aphidicolin (Aphid). The blue bars 
represent the absolute recovery of each treated sample in relation to its input. 0.66 pmols of G-
AID deaminated 0.3 % of the total plasmids. Red bars represent the repair pathways activated 
when 1 unit of UGI is incubated with 150 µg of FE 10 min on ice prior repair reaction. B) G-AID 
mt results were subtracted from G-AID WT results. From 55 % to 88 % of the total repair activity 
was inhibited by UGI, depending on G-AID concentration used. Error bars indicate SD (n = 3). 
Time line of the experiment is shown above the graph. C) SC plasmids were treated with 0.66 
pmols of G-AID WT or mt and then incubated with different amounts of FE. D) G-AID mt results 
were subtracted from G-AID WT results. Error bars indicate SD (n = 3). Time line of the 
experiment is shown above the graph. 
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3.4 - IVR IS SUITABLE FOR QUANTIFYING DNA REPAIR ACTIVATION IN 
DIFFERENT CELL LINES  
 
To obtain a more cancer and B cell line relevant biochemical analysis and to link 
biochemical data with biological information, I established the IVR using human cell lines. 
Using different cell lines (from different tissues) we can correlate functional aspects of 
DNA damage repair with physiological aspects of different cellular milieu. This allows us to 
determine if a cell’s microenvironment can influence AID-induced lesions processing and 
analyse the coordination between different DNA repair networks required for maintaining 
stability. We performed the IVR resolution phase using extracts from: human B cell lines 
(Ramos and BL2) and human epithelial cell lines (HelaS3 [cervical] and Colo704 
[ovarian]). Those cell lines were selected because of their ability to grow fast and in 
suspension, allowing for a more reproducible extract preparation.  
Our emphasis was to compare B cells environment with non-B cells environment and to 
characterize single repair pathways activation after DNA damage by AID. For example, 
Ramos is a Burkitt's lymphoma cell line that constitutively express AID and undergoes 
SHM (169), thus we were expecting a cellular environment prepared to respond differently 
to the AID-induced damage.  
Before using cellular extracts in IVR assay, we checked that the extracts preparation 
protocol leads to the purification of active DNA repair proteins. We started the analysis by 
evaluating SSBR capacity of each extract (Figure 18). SC plasmids were treated with 
nicking enzymes and then used in the second phase of IVR. Repair activity detected in 
different extracts when plasmids were nicked was 4 to 7 fold higher (Figure 18 - turquoise 
bars) compared to not treated plasmids (set to 1). When CIP treatment was performed to 
reduce the number of self-ligations and thus to increase the number of damaged 
plasmids, we scored an increase in repair activity (Figure 18 - blue bars). On the contrary, 
when FE was used to repair a plasmid nicked and de-phosphorylated, a reduction was 
registered. This can be due to specific repair proteins turnover in different extracts.  
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Figure 18 – Quantification of SSBR in different cellular extracts 
IVR was performed using a modified substrate. Plasmids were either digested or not with AlwI 
nicking enzyme. After enzyme heat inactivation, plasmid was treated or not with CIP enzyme. 
Purified plasmids were then repaired by FE, Ramos and HelaS3 extracts (with bio-dC) in the 
presence of aphidicolin (aphi). Results from untreated plasmids (ND = not digested) were set to 
one. Time line of experiment is shown next to the graph. 
 
After confirming that cell extracts are able to perform DNA repair, we evaluated extracts 
competency in the IVR assay (Figure 19).  
 
Figure 19 – Extracts competence for IVR assay  
SC plasmids were treated with 0.66 pmols of G-AID, G-AID mt or (-) and then incubated with 
different cellular extracts. The blue bars represent the absolute recovery of each treated sample 
in relation to its input. Red bars represent the repair pathways activated by G-AID mt and green 
bars represent extracts-induced repair activity (without the addition of DNA damaging proteins). 
Error bars indicate SD (n = 3). Time line of the experiment is shown next to the graph. Statistical 
analysis (t-test) was performed on differences of indicated pg % input; * indicates p values < 0.05. 
 
In the absence of G-AID the extracts were not providing nicking activity, as no DNA repair 
machinery was activated (Figure 19 - green bars). Different cell lines displayed significant 
repair activity only if G-AID was added to the SC plasmid, indicating that, similar to the FE, 
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G-AID catalytic activity is required to initiate DNA repair (Figure 19 - blue bars). As 
expected, different cell lines displayed different repair activity. 
 
3.5 - ANALYSIS OF SINGLE REPAIR PATHWAYS ACTIVATED BY DIFFERENT CELL 
LINES UPON AID-INDUCED DAMAGE  
 
To distinguish which repair pathways were responsible of differential AID-induced damage 
repair in different extracts, a more detailed analysis was performed with IVR assay. 
In particular, dU lesions can be recognized by two pathways: BER and MMR. BER can be 
subdivided into SP-BER and LP-BER, specialized in replacing only uracil or up to 10 
bases surrounding uracil, respectively. Furthermore, four different glycosylases can 
initiate BER: UNG and STM (SMUG1, TDG or MBD4). MMR can be classified into clMMR 
and ncMMR, if error-free or error-prone polymerases are recruited, respectively. 
Depending on the acting repair pathway different nucleotides can be incorporated, for 
example dA will be incorporated only if long patches of DNA are removed and replaced. 
As stated, IVR was performed in the presence of aphidicolin, to inhibit replication-
dependent biotin incorporation. However, aphidicolin is also inhibiting Pol δ/ε, which can 
be part of LP-BER and clMMR (170,171). LP-BER can also occur with Pol β, a 
polymerase involved in SP-BER (172). ncMMR is an alternative to clMMR and utilizes 
other error prone polymerases (53). The repair pathways utilizing bio-dC incorporation in 
the presence of aphidicolin are: SP-BER, LP-BER (Pol β dependent), and MMR (Pol η 
dependent). Although still in the presence of aphidicolin, detailed analysis of single DNA 
repair pathway usage was performed using different concentrations of cellular extracts (x 
axis - Figure 20): A) bio-dC incorporation (Figure 20A), B) bio-dC incorporation and 
extract treatment with UGI (Figure 20B) or 3) bio-dA incorporation (Figure 20C). Single 
repair pathways that are activated in each condition are indicated below each chart 
(Figure 20): A) bio-dC is incorporated by both BER and MMR, B) if UGI is used, bio-dC 
will be incorporated by MMR and BER-STM dependent and 3) bio-dA will be incorporated 
by MMR and LP-BER pathways.  
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 Figure 20 – IVR assay is suitable for studying AID-induced damage resolution in different 
cell lines 
A) SC plasmids were treated with 0.66 pmols of G-AID WT or mt and then incubated with 
increasing amounts of HelaS3 and Ramos extracts (X-axis). Reaction was performed in the 
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presence of bio-dC. Deaminated and repaired plasmids were isolated and quantified as % of 
input (total amount of plasmids). G-AID mt results were subtracted from G-AID WT results. U 
indicates UNG glycosylase, while STM includes SMUG1, TDG or MBD4 glycosylases. Error bars 
indicate SD (n = 3). Time line of the experiment is shown below the graph. Pathways activated in 
this IVR assay are indicated in the panel below the chart.  B) Increasing amounts of HelaS3 and 
Ramos extracts were incubated with 1 UGI unit. Reaction was performed in the presence of bio-
dC. Pathways activated in this IVR assay are indicated in the panel below the chart. Error bars 
indicate SD (n = 3). Time line of the experiment is shown below the graph. C) SC plasmids were 
treated with 0.66 pmols of G-AID WT or mt and then incubated with increasing amounts of 
HelaS3 and Ramos extracts. Reaction was performed in the presence of bio-dA. Pathways able 
to incorporate bio-dA are indicated in the green table. Error bars indicate SD (n = 3). Time line of 
the experiment is shown below the graph. Pathways activated in this IVR assay are indicated in 
the panel below the chart. Statistical analysis (t-test) was performed on differences between A 
and C in Ramos and HelaS3. * p values are indicated in the figure. 
 
 
HelaS3 extract was as efficient as Ramos extract in repairing AID-induced lesions (Figure 
20A). In both extracts the maximum activity was reached at 20 µg. In the presence of UGI 
inhibitor, the repair activity was reduced (Figure 20B). In the Ramos extract, this inhibition 
was dependent on proteins concentration: hardly detectable at low concentrations, while 
more than half of the repair activity was inhibited at maximum concentration (40 µg – 
Figure 20B). In HelaS3 extract BER-UNG activity was independent from concentration. 
Furthermore, when bio-dA was incubated with the extracts, BER and MMR were more 
active in Ramos extract compared to HelaS3 extract (Figure 20C).  
To better unravel the single repair pathways recruitment upon AID-induced lesion we 
decided to combine data from bio-dC and bio-dA incorporation with single or multiple 
specific inhibitors: UGI, T2AA and aphidicolin. UGI and aphidicolin were described before. 
T2AA is a small peptide able to inhibit PCNA interaction with proteins containing a PIP-
box motif (161), including Pol δ and with low affinity also Pol ε and TLS polymerases. The 
only pathway unaffected by PCNA inhibition is SP-BER. Alternatively, some repair activity 
can still be observed if the ring-shaped heterotrimeric 9-1-1 complex (composed of Rad9, 
Rad1 and Hus1 proteins), a PCNA relative, is loaded at damaged sites, where it serves as 
platform for the selective recruitment of repair proteins. Although 9-1-1 clamp seems to 
play a major role in HR and template switching, it was shown to physically interact with 
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EXO1 (173) and TDG glycosylase (174); it is not clear how much and if it plays a role in 
BER and MMR of our extracts.  
Titration experiments with UGI, aphidicolin, and T2AA identified optimal inhibition 
concentrations (data not shown). 1 unit of UGI, 0.2 mM T2AA and 5 µg of aphidicolin were 
used to inhibit their targets in 20 µg of cellular extracts (5-10 fold in excess respect to 
minimum inhibitory concentration).  
The strategy used to identify single repair pathways involvement in AID-lesion repair can 
be derived from the Table in Figure 21.  
 
Figure 21 – Tabular representation of the strategy used to identify single repair pathways 
involvement in AID-induced damage repair 
A) Repair pathways able to recognize and process dU lesions are indicated in the first row. 
Pathways unaffected by single inhibitor (or combinations of different inhibitors) are identified by 
the check mark. G-AID is the result of G-AID mt subtraction from G-AID WT. B) Calculations 
performed to derive single repair pathways involvement in AID-induced damage repair. Numbers 
refer to the first column in Figure A. 
 
Subtracting results between the identified pathways we could calculate the single 
pathways involvement in repairing AID lesions (Figure 17B). For example, SP-BER (UNG-
dependent) was calculated subtracting IVR results derived from incubation of the extracts 
with aphidicolin and T2AA from IVR results derived from the use of three inhibitors 
(aphidicolin, T2AA and UGI), in the presence of bio-dC. Thus, the contribution of 5 major 
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repair pathways to AID-lesion repair could be independently quantified: 1) SP-BER (UNG-
dependent), 2) SP-BER (STM-dependent) and repair 9-1-1 dependent, 3) LP-BER (UNG-
dependent), 4) ncMMR and LP-BER (STM-dependent) and 5) clMMR (Figure 21B). 
This strategy was employed to charachterize 4 cellular extracts (HelaS3, Colo704, Ramos 
and BL2) (Figure 22) and the FE (Figure 23). The total repair activity (red line - Figure 22) 
and the contribution of single repair pathways to AID damage resolution (bubbles of 
different grey scale - Figure 22) were calculated using 4 different concentrations of 
extracts (x axis - Figure 22). All the cellular extracts analyzed displayed a maximum repair 
activity at 20 µg, while with higher concentrations an inhibitory effect was observed. 
Overall the following trends in single repair activities were observed: 1) ncMMR was 
predominantly activated at higher concentrations of extracts, 2) clMMR was more active in 
non-B cell extracts and at lower concentrations, 3) in B-cell extracts SP-BER activity was 
inversely proportional to the concentration of extract used, with strong activation at lower 
concentration (while ncMMR activity is predominant at higher concentrations), 4) LP-BER 
activity was variable depending on the concentrations of extracts used; in B cell extracts 
LP-BER was predominant when maximum repair activity was observed, while in the same 
conditions it was barely visible in non-B cell extracts.  
We conclude that the concentration of active repair proteins is fundamental for single 
repair pathway activation and could play a role in the inhibition or compensation exerted 
toward other repair pathways.   
The same analysis was performed using FE and only at 150 µg the extract displayed the 
maximum repair activity, while no inhibitory effect was reported (Figure 23 - red line) even 
at higher concentrations (data not shown). This may be an indication of repair kinetics: 
substantially high number of active repair molecules may be required to trigger repair 
pathways activation. Comparably to B cell extracts, the FE displayed strong SP-BER 
activation at lower concentrations of extract, while the other repair pathways reached the 
same repair activity independently from the concentration used.   
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Figure 22 – Quantification of single repair pathway activation upon AID damage in IVR 
assay using different cellular extracts 
One, 5, 20 and 40 µg of cellular extracts (x axis) (A = HelaS3, B = Colo704, C = Ramos, D = 
BL2) were used. Total repair activity (red line) was calculated as absolute % of bio-dC 
incorporation in the absence of inhibitors, and subtracting the extract specific replication activity. 
For DNA repair pathway contribution each data point in the red line was set to 100 and repair 
pathways contribution was represented as bubbles (bubble diameter = %). Grey scale represents 
different repair pathways. Images are the average of 3 independent experiments. 
 
Figure 23 – Quantification of single repair pathway activation upon AID damage in IVR 
assay using FE 
One, 20, 100 and 150 µg of FE (x axis) was used to repair in vitro AID-induced lesion. Total 
repair activity (red line) was calculated as absolute % of bio-dC incorporation in the absence of 
inhibitors, and subtracting the extract specific replication activity. For DNA repair pathway 
contribution each data point in the red line was set to 100 and repair pathways contribution was 
represented as bubbles (bubble diameter = %). Grey scale represents different repair pathways. 
Images are the average of 3 independent experiments. 
 
To have a better overview of single repair pathways involvement in AID-induced damage 
repair, IVR results derived from maximum repair activity were represented in pie charts 
(Figure 24A). The cellular extracts displayed maximum repair activity at 20 µg while FE 
repair activity was complete only at 150 µg (Figure 24B). A non B-cell extract, Colo704, 
was 2 to 3 fold more efficient then other extracts in repairing AID lesion.  
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Figure 24 – Detailed analysis of single repair pathways contribution to maximum IVR 
activity 
A) IVR results obtained with 20 µg of cellular extracts and 150 µg of FE were represented in pie 
charts. % of single repair pathways contribution to maximum repair activity are indicated in the pie 
charts. The orange portion of the pie charts correspond to SP-BER and 9-1-1 dependent repair, 
the turquoise portion correspond to ncMMR and LP-BER (STM-dependent). B) IVR total repair 
activity is represented as absolute recovery in relation to input, using different concentration of 
extracts or FE. 
 
We observed that MMR (cool colours – Figure 24A) and BER (warm colours – Figure 
24A) contributed to AID damage resolution. Comparing different B and non-B cell extracts, 
LP-BER activation was predominant in B cells extracts, while it was almost absent in non-
B cell extracts. As observed in Figure 17A, UNG-dependent BER is the major repair 
pathway activated by FE to repair AID-induced lesion (yellow and red account for 57 % of 
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the total repair – Figure 24A). The pie chart analysis recapitulated the results observed in 
Figure 20C. Considering total repair activation, LP-BER and MMR activation is higher in 
Ramos extract (red and cool colours account for 72 % of the total repair – Ramos - Figure 
20A) compared to HelaS3 extract (red and cool colours account for 51 % of the total 
repair – HelaS3 – Figure 20A). From Figure 20C we derived that using 20 µg of Ramos 
extract, 78 % of the plasmids incorporate bio-dA (LP-BER and MMR); while using 20 µg of 
HelaS3 extract, 57 % of the plasmids incorporate bio-dA. This is an indication of the 
consistency of the IVR for determining single repair pathways activity. Minor differences 
observed between the two experiments (Figure 20C and Figure 24A) could be technically 
or due to crosstalks and compensatory mechanisms of the DNA repair.  
Interestingly, in Ramos, ncMMR, an error prone repair mechanism, is lower compared to 
other extracts. As B cells needs introduction of mutation we were expecting an opposite 
trend, with more error-prone repair pathway activation. This could be due to Ramos cell 
background, as SHM and AID are constitutively active, and thus a specific response to 
continuous mutation stimulation could have evolved. Alternatively, mutation incorporation 
can also be performed with other repair pathways, for example during LP-BER activation, 
if translesion polymerases are recruited.   
Ramos and BL2 extracts displayed some similarities (for example higher LP-BER 
activation compared to non-B cell extracts) and some differences (for example in MMR 
activation). It would be then interesting to induce endogenous AID expression in BL2 to 
see if the repair profile became more similar to Ramos profile. 
We concluded that different cell lines and FE quantitatively activate different repair 
pathways to repair AID lesion. Other processes can interfere with the dU repair activity, 
such as chromatin conformation, specific signal transduction, protein interacting with 
repair pathways, rate of mutations, cell replication state and many others. 
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3.6 - MMR AND BER PROTEINS ARE DIFFERENTIALLY EXPRESSED IN B CELL 
EXTRACTS AND NON-B CELL EXTRACTS  
 
To understand why different cell lines displayed different activity after encountering AID-
induced damage, we performed a more detailed analysis. First, we checked the amount of 
some of the DNA repair protein present in each extract (Figure 25A). Surprisingly, EXO1, 
a key protein of MMR, was more abundant in non B-cell extracts, while UNG and MBD4 
glycosylases that initiate BER were more abundant in B cell extracts (Figure 25B). FE was 
mostly enriched in UNG, while MBD4 did not seem to contribute to BER in FE.   
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Figure 25 - BER and MMR protein expression in different cell lines 
A) Western Blot analysis using different antibodies was performed using 20 µg of FE, Ramos, 
BL2, HelaS3 and Colo704 extracts. Differences in bands position between human and xenopus 
proteins are due to different molecular weight, for example Xenopus EXO1 is known to be 77 kDa 
compared to the human EXO1 (95 kDa). Multiple bands are possibly due to the presence of 
different human isoforms: 5 in UNG and 6 in MBD4. B) EXO1, UNG and MBD4 were normalized 
to tubulin in each extract. Values are expressed as integrated density. Image-J program was 
used to calculate bands relative area and density. Further calculations were performed to remove 
background specific for each single band. 
 
Although we identified differences in repair protein expression, there was no evidence for 
a direct correlation with IVR activity. A more precise analysis should consider also the 
catalytic activity of these enzymes.  
 
3.7 - ANALYSIS OF BER PROTEINS ACTIVITY IN DIFFERENT CELL EXTRACTS  
 
To correlate repair protein amount with IVR resolution, we checked if repair protein 
amount is directly related to repair protein activity. Using a quantitative dsDNA 
oligonucleotide DNA glycosylases assay, we determined the activity of various DNA 
glycosylases enzyme able to recognize uracil (UNG, SMUG, TDG or MBD4) and initiate 
SP-BER (Figure 26A). ds oligonucleotides with a single U:G mismatch were incubated 
with cell extracts to generate UNG-dependent abasic sites, processed by APE and NaOH 
to cleave at the abasic site. Depending on DNA glycosylases activity, oligonucleotides will 
be cleaved and will run at a different position; measurement of the oligonucleotides 
cleavage is therefore a direct measurement of DNA glycosylases activity. Specificity of the 
assay was determined by incubating ss or ds oligonucleotides with commercial UNG or 
ENDO III enzymes (Figure 26B). UNG alone was able to cleave only a small portion of the 
oligonucleotides, ENDO III alone was not active in cleaving the DNA backbone if the uracil 
base was still present, while combining both enzymes activities we could achieve almost 
100 % of cleavage, using both ss and ds oligonucleotides.  
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Figure 26 - ds oligomucleotide DNA glycosylases assay is suitable to evaluate DNA 
glycosylases activity in different cellular extracts 
A) Schematic representation of ds oligonucleotide DNA glycosylases assay. 2.5 pmols of ds 
oligonucleotides with single U:G mismatches were incubated 15 min at 37°C with cell extracts, 
which contained DNA glycosylases enzymes (UNG, SMUG1, TDG and MBD4). Cleavage of the 
oligonucleotide was enhanced with NaOH addition. Cleaved oligonucleotides run faster on the 
17.5 % PAGE gel. B) Commercial purified enzymes (UNG and ENDO III) were incubated 15 min 
at 37°C with 2.5 pmols of ss or ds oligonucleotides. Combination of the two enzyme lead to a full 
cleavage of the U:G oligonucleotide (lower band). C) different concentration of HelaS3 extract (0 
to 60 µg) were incubated 15 min at 37°C with 2.5 pmols of ds oligonucleotides and run on the 
17.5 % UREA PAGE gel. DNA glycosylases present in HelaS3 extract were able to cleave the 
U:G oligonucleotide; DNA glycosylases activity increased with increasing amount of extract D) 
Activity of DNA glycosylases in increasing concentrations of HelaS3 extract was calculated as % 
of oligo conversion. Red dotted line derived maximum activity from plateau. ImageJ program was 
used to calculate bands relative area and density. Further calculations were performed to remove 
background specific for each single band. % of conversion was calculated as: intensity lower 
band*100/[intensity upper band + intensity lower band].  
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We tested our cellular extracts competency by incubating increasing amount of extracts 
with a fixed amount of oligonucleotides (Figure 26C). There was a linear correlation 
between DNA glycosylases activity and global protein content, until a plateau phase was 
reached (Figure 26D). A threshold was set to identify maximum % conversion (Figure 26D 
– red line).  
 
3.7.1 - UNG activity is dominant over the other DNA glycosylases activities 
  
Comparing DNA glycosylases activity in HelaS3 extract and Ramos extract, we observed 
some differences (Figure 27A). In HelaS3 a more sensitive response was observed, with 
few µg of extract containing already enough DNA glycosylases activity to process 50 % of 
the substrate. Maximum activity is achieved using 20 µg of extract and corresponds to 65 
% of conversion, before a plateau is observed. In Ramos extract a slower activation profile 
was registered, with maximum activity (70 % of conversion) reached at 30 µg.  
Using UGI we separated UNG activity from STM activities (Figure 27B). Increasing 
concentrations of UGI were incubated with the extract concentration that corresponded to 
maximum repair activity (20 µg for HelaS3 and 30 µg for Ramos – red squares in Figure 
23A). 0.05 units of UGI were sufficient to reduce UNG activity. As expected, UNG activity 
was dominant over the other DNA glycosylases, as the remaining activity (STM 
dependent) was below 10 % in both HelaS3 and Ramos extracts. 
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Figure 27 - UGI decreases DNA glycosylases activity in ds oligonucleotide DNA 
glycosylases assay 
A) Increasing concentrations of HelaS3 and Ramos extract were incubated 15 min at 37°C with 
ds oligonucleotides and run on 17.5 % PAGE gel. DNA glycosylases activity increased with 
increasing amount of extract. B) Increasing units of UGI inhibitor were incubated on ice 10’ min 
with 20 and 30 µg of HelaS3 and Ramos extracts, respectively. The extract was subsequently 
used for a ds oligonucleotide DNA glycosylases assay, as previously described. ImageJ program 
was used to calculate bands relative area and density. Further calculations were performed to 
remove background specific for each single band. % of conversion was calculated as: intensity 
lower band*100/[intensity upper band + intensity lower band].  
 
Interestingly, when UGI titration was performed using a concentration of extract that was 
not corresponding to the maximum DNA glycosylases activity (i.e. 10 µg) we could not 
observe a linear decrease in DNA glycosylases activity (Figure 28) This was seen in the 
Colo704 extract, but similar results were also obtained with other extracts (data not 
shown). As UGI inhibits only active UNG molecules, this phenomenon could be explained 
by a concentration dependent activation of UNG molecules and possibly dimer formation. 
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Figure 28 – UGI inhibition on not completely active UNG molecules from Colo704 extract  
Increasing units of UGI inhibitor were incubated on ice 10’ min with 10 µg of Colo704 extract. The 
extract was subsequently used for a ds oligonucleotide DNA glycosylases assay, as previously 
described. ImageJ program was used to calculate bands relative area and density. Further 
calculations were performed to remove background specific for each single band. % of 
conversion was calculated as: intensity lower band*100/[intensity upper band + intensity lower 
band].  
 
3.7.2 - Number of active DNA glycosylases molecules does not directly correlate 
with BER activity 
 
Contribution of different DNA glycosylases to uracil excision from DNA was quantified in 
different extracts (measured in pmol of oligonucleotides converted in 1 min by 1 µg of 
extract from the ds oligonucleotide DNA glycosylases assay) and in all the extracts UNG 
activity was dominant over the other UNG glycosylases. SMUG, TDG, and MBD4 had 
only a minor role in recognising uracil in our extracts (Figure 29A). In B-cell lines, a higher 
UNG activity per µg of extract was observed, compared to non-B cell lines. 
As UGI is interacting 1:1 in molar stoichiometry with UNG (175),one can extrapolate the 
moles of active UNG enzyme for each extract (Figure 29B), while the Western blot (Figure 
25) identified the total number of UNG molecules. With FE contained the highest number 
of UNG molecules, up to 6 times more than the other cellular extracts. Comparing the 
number of active UNG molecules with UNG activity, we determined UNG turnover for 
each extract (Figure 29C). Surprisingly, FE proteins had the lowest turnover, meaning that 
a high number of active molecules of UNG from FE are necessary to give small activity.  
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Figure 29 - Quantification of DNA glycosylases activity, concentration and turnover in 
different cell extracts 
A) The assay was performed as previously described. Ratio of cleaved oligonucleotides is based 
on to 2.5 pmol of oligonucleotide input used and calculated as fmol of oligonucleotide cleaved in 
1 min by 1 µg of extract. UNG is separated from other UNG enzymes using UNG2 specific 
inhibitor (UGI); remaining activity was due to STM (SMUG, TDG and MBD4 activity- orange 
colour) and was related to maximum DNA glycosylases activity. B) Active UNG concentration 
was derived from UGI (24 pmol/ 2 units) 1:1 interaction with UNG molecules. We derived the fmol 
of active UNG present in 1 µg of extract. C) Turnover was calculated from the ratio between 
activity of UNG and number of active UNG molecules. Error bars indicate SD (n = 3). 
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We conclude that in FE, UNG is slow in the recognition and removal of uracil, while few 
molecule of active UNG in BL2 extract are enough to give a fast and high activity in 
removing uracil. Using BL2 and Colo704 extracts a higher BER activation upon AID-
induced damage was observed, contrary to FE. 
Specific subpathways active in FE could be responsible for its kinetics of repair; SMUG, 
TDG and MBD4 provide 32 % of the total uracil excision (Figure 29A – orange column), 
and this activity may in turn be related to slow activation. Interestingly, the slow UNG 
turnover displayed by FE, could be correlated to IVR activity: 150 µg of FE were needed 
to reach the maximum repair activity upon AID-damage (Figure 23 and 24B), while in all 
the other extracts the repair activity was already saturated after 20 µg.  
SP-BER activation analysis revealed that UNG activity is predominant over SMUG, TDG, 
and MBD4 (STM) activation in repairing AID lesions (Figure 29A). If we compare these 
observations with IVR results (Figure 24A), we can appreciate some differences in SP-
BER glycosylases contribution to AID-damage resolution. We decided to integrate IVR 
results (Figure 24A) with specific contribution of DNA glycosylases to SP-BER (Figure 
29A), to generate a more detailed analysis (Figure 30).  
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Figure 30 - Integrated analysis of single repair pathways contribution to maximum IVR 
activity 
IVR results presented in Figure 24 were integrated with results obtained from ds oligonucleotide 
DNA glycosylases assay. Relative activities of SP-BER UNG and STM dependent calculated in 
Figure 24A were substituted to SP-BER (UNG) and SP-BER (STM) activities calculated with IVR.   
 
Differences between Figure 24A and Figure 30 could be explained as follow: when we 
performed IVR analysis we were not able to separate SP-BER STM-dependent repair 
from 9-1-1 dependent repair. Moreover, SP-BER IVR analysis was performed using 
chemical inhibitors, thus compensatory mechanisms derived from chemical inhibition of 
specific pathways could have influenced the analysis.  
Surprisingly, IVR analysis performed with FE was not visibly changed when integrated 
with uracil assay analysis (compare FE in Figure 24A and in Figure 30), meaning that no 
compensatory mechanisms occurred when UNG was chemically inhibited during IVR 
assay. Interestingly, FE was the only extract displaying a significant STM glycolylases 
activation (14 % - orange portion in FE Figure 30), indicating that UNG inhibition did not 
lead to an increase in STM activation to repair AID lesion.  
On the contrary, in the cellular extracts IVR analysis revealed that STM-induced SP-BER 
activation was predominant over UNG contribution (Figure 24A). Integrating analysis with 
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dsDNA oligonucleotide DNA glycosylases assay we observed the opposite trend, with 
predominant UNG activation (Figure 30). This indicated that in cellular extracts, when 
UNG is inhibited a compensatory mechanism is activated, with an increase in SMUG, 
TDG and MBD4 activation.  
Compensatory mechanisms are observed only in IVR assay and not in dsDNA 
oligonucleotide DNA glycosylases assay because a small oligonucleotide does not allow 
all the repair pathways to be active and to establish crosstalks. This hypothesis included 
the possibility that other proteins, activate only during IVR, are interfering and activating 
STM. 
 
3.8 - TRASCRIPTIONAL ACTIVITY DOES NOT SEEM TO INFLUENCE IVR READOUT  
 
We also checked the global transcriptional activity of different cell extracts, since both 
DNA repair and AID activity can be coupled to transcription (51,126,127). In the standard 
transcriptional assay a known DNA was incubated with the cell extracts, RNA was 
isolated, retrotranscribed and quantified (Figure 31). In FE, a minimal transcriptional 
activity was reported, while Ramos and another B cell line (DT40) produced extracts with 
the highest competency for transcription. The two epithelial cell lines displayed differential 
behaviour, with Colo704 being 5 fold more active in transcription compared to HelaS3. 
The FE’s low transcriptional competence may be related to slow activation in recognition 
of the damage and activation of repair, or may be related to Xenopus oocytes peculiar 
maturation, via 12 rounds of DNA replication and cell division, without mRNA formation 
(176)  
Although we identified differences in transcriptional activity, there was no evidence for a 
direct correlation with IVR activity. 
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Figure 31 - Transcriptional competence of extracts   
Transcriptional activity of each extract was tested with HelaScribe Nuclear Extract in vitro 
Transcription System from Promega; RNA formation was monitored by RT-qPCR. Values are 
normalized over negative control (extracts incubated with no HelaScribe DNA addition) and FE 
was set to 1. Except for FE, all extract are transcriptionally competent. 
 
3.9 - CELL CYCLE STATE CONTRIBUTION TO DNA REPAIR PROTEIN 
AVAILABILITY IN THE RESOLUTION OF AID-INDUCED DAMAGE  
 
Differential repair protein availability in the extracts could be due to proteome dynamics 
during cell cycle progression, and thus extract preparation could influence IVR repair 
activity. We synchronised cells in S/G2 phase with nocodazole to determine if the extract 
expression profile could alter the IVR readout. For each cell type we performed a titration 
analysis of nocodazole, measuring efficacy (growing curve of Ramos cells - Figure 32A) 
and toxicity (tryphan blue staining of dead Ramos cells - Figure 32B). Among the different 
concentrations of nocodazole used, 5, 10 and 20 ng per mL of culture were still not 
effective in blocking cell proliferation (Figure 32A – dotted lines). For synchronization we 
selected a concentration that provided an effective cell cycle block and with low toxicity 
(40 ng), and cells were incubated 14 to 16 hours before harvesting.   
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Figure 32 - Analysis of nocodazole efficacy and toxicity 
A) Different concentrations of nocodazole (0 - 70 ng of nocodazole/mL of culture) were incubated 
24 hours with Ramos cells (or HelaS3 cells, not shown). Cells were counted at different time 
points using tryphan blue. Concentrations reported by the dotted lines are not efficient in blocking 
cell cycle progression. B) Toxicity experiment was performed in parallel with A), % of death cells 
is reported after 24 h of nocodazole treatment, cells were counted with tryphan blue solution and 
hemocytometer. 
 
Efficacy and toxicity were further tested with propidium iodide (PI) and anti-caspase3 
staining during FACS analysis. Apoptotic cells accounted for 10 % of total (data not 
shown) and were removed prior to extract preparation. Almost 80 % of HelaS3 cells and 
84 % of Ramos cells were trapped in S/G2 phase (blue and second red peak in the 
synchronisation model – Figure 33 A and 33C).  
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Extracts were tested in the IVR, and preliminary results indicate that there is no difference 
in IVR activity if HelaS3 cells were synchronized or not (Figure 33B), while for Ramos 
cells we observed some differences (Figure 33D), but further work is needed to determine 
statistical significance and single DNA repair pathway usage. 
 
Figure 33 - Analysis of HelaS3 and Ramos synchronisation 
A) HelaS3 cells were were synchronized with 40 ng/mL nocodazole for 16h, while. Cell cycle 
status was checked by FACS analysis after PI staining. Results were analysed with the 
synchronization wizard model. DNA content is indicated on the X-axis, while number of cells is 
reported on the Y-axis. First red peak is G1 phase, blue region is S phase and second red peak is 
G2 phase. % of relative phases are reported. After nocodazole treatment most of the cells were in 
S/G2 phase. B) IVR was performed using different concentrations of HelaS3 extracts 
synchronized or not. G-AID mt results were subtracted from G-AID WT results. C) Ramos cells 
were synchronized with 40 ng/mL nocodazole for 14h and analysis was performed as described 
in A. D) IVR was performed using different concentrations of Ramos extracts synchronized or not. 
G-AID mt results were subtracted from G-AID WT results. 
 
3.10 - B CELL EXTRACTS ARE ENRICHED IN HISTONES COMPARE TO NON-B 
CELL EXTRACTS  
 
Besides studying contribution of cellular microenvironment, transcription, and cell cycle to 
AID damage resolution, we also dissected the effect of nucleosomes and nucleosome 
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formation for our DNA damage response. Chromatin status could interfere both with AID 
deamination reaction and with DNA repair reaction. It is known that AID can target DNA 
sequences wrapped around nucleosomes only during transcription, which could have 
displaced nucleosomes (177). While chromatin compaction can also impede access of 
DNA repair protein to the damaged sites (178). We wanted to determine if the various 
extracts were able to form nucleosomes around the supercoiled plasmids used in the IVR 
assay, and if nucleosomes and other epigenetic characters influenced the IVR reaction. 
To this end, we analysed the histones abundance in different extracts by Western Blot 
analysis (Figure 34A). Normalizing H3 fraction over the total cytosolic fraction (tubulin) we 
observed that, B-cell extracts are more enriched in H3 while non-B cell extracts have up to 
50 times less H3 protein (Figure 34B). Using H3 protein as standard we could also 
quantify the ng of H3 contained in 1 µg of Extract: Ramos and BL2 contained more than 
12 ng of H3 per µg of extract (Figure 34B).  
Low abundance of histones in Colo704 extract could be related to high IVR repair activity, 
as one can hypothesize that this DNA is more accessible to repair proteins. However, in 
HelaS3 extract we did not observed the same behaviour: even in the presence of few 
histones its repair activity is comparable to the one exerted by Ramos and BL2 extracts. 
We conclude that histones abundance is not directly related to IVR activity. 
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Figure 34 - Analysis of histones expression in different cell lines 
A) Western Blot analysis using anti H3 antibody was performed in FE, Ramos, BL2, HelaS3 and 
Colo704. Overexposition showed that also HelaS3 extract contains some histones B) H3 was 
normalized on tubulin amount present in each extract. Values of the left chart are expressed as 
integrated density. Image-J program was used to calculate bands relative area and density. 
Further calculations were performed to remove background specific for each single band. Values 
of the right chart are expressed as ng of H3 in 1 µg of extract. ng of H3 were calculated from 
western blot analysis of purified H3 protein.  
 
3.11 - ANALYSIS OF DNA SUBSTRATES ABLE TO ALTER THE CHROMATIN 
COMPACTION  
 
Nucleosome formation is not exclusively related to histones abundance, but can also be 
influenced by specific DNA sequences. To check if the repair of supercoiled plasmid used 
in IVR is altered by nucleosome formation, we tested plasmid sequences with differential 
affinity for nucleosomes. 
It is known that both base pairing and base stacking contribute to DNA double helix 
stability (179). AT pairing can be destabilizing and adjacent bases have a role in 
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determining the fluctuational opening of the DNA double helix (179). Stacked/closed and 
unstacked/open conformations are governed by stacking negative Gibbs free energy (-
ΔG): higher ΔG correlate with dynamism. The chicken Ig lambda locus was analysed for 
the stacking ΔG of overlapping 30 consecutive bases (Figure 35) (180)  Probabilities of 
occupancies of closed and opened DNA conformations were determined. In particular, a 
region between variable and constant genes (74 % AT composition) was identified as not 
compatible with nucleosomes formation, while a closed region (54 % GC composition) 
was selected for its high probability to associate with histones (Figure 35). The two 
regions were named “low nucleosome (LN)” and “high nucleosome (HN)” forming regions, 
respectively. HN region was PCR amplified and cloned into the pGL3.41 backbone. Due 
to high AT content in the LN template, it was not possible to get a specific product, thus 
the LN region was purchased from Genescript and cloned into the pGL3.41 backbone.  
 
Figure 35 - Chicken variable and constant regions analysis for affinity with nucleosomes 
formation 
Stacking -ΔG of overlapping 30 consecutive bases was analysed and regions with high -
ΔGs (yellow) were separated from regions with low -ΔG (turquoise).  
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3.11.1 - pEI7150 has regions reluctant to form nucleosomes and pEI7151 has 
regions prone to form nucleosomes 
 
Nucleosomes formation on those sequences was validated with Atomic Force Microscopy 
(AFM). AFM has been used to visualise plasmids in the past (160). It is a quantitative and 
qualitative tool, as AFM can measure real physical distances and single strandedness, as 
well as identify bound proteins (e.g. nucleosomes). Using multiple approaches, we 
visualised DNA using polyornithine-coated MICA surfaces to modulate the electrostatical 
repulsions between DNA phosphates and MICA. Images were obtained from a 
Nanowizard AFM (JPK Instruments) in AC mode in air (Figure 9), to image molecules 
more gently and without moving them. Indeed, in AC mode, the tip is intermittently 
contacting the surface with constant oscillation, without being trapped by adhesive forces 
coming from sample. 
Both LN/HN inserts and their respective final plasmids (pEI7150 and pEI7151, 
respectively) were imaged, checking for plasmid integrity and topology (Figure 36A and 
36B). No major differences were observed between the two plasmids. 
Specific DNA sequence patterns are favoured for DNA bending and packaging in 
chromatin, in particular the 601 DNA was shown to bind with high affinity histones 
octamers to form nucleosomes in vitro (181). To verify nucleosome formation with AFM 
601 DNA was used in a nucleosome reconstitution assay; incubating the DNA template 
with the core histones in the presence of high concentrations of NaCl. This allowed for the 
proper deposition of positively-charged histones onto the negatively-charged DNA and to 
prevent undesired interactions of the histones with other molecules. Various ratios of 601 
DNA and recombinant octamer were combined to find the optimal conditions for the 
complex formation, with a nearly 2:1 molar ratio of histones to 601 DNA selected (160 
fmols of DNA and 280 fmols of histones octamer) (data not shown). After dialysis, 
nucleosomes in low salt concentration were visualized with AFM as compacted and higher 
molecules, compared to the non-treated DNA (Figure 36C).  
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Figure 36 - Different plasmids topology and nucleosome formation visualization with AFM 
A) pEI7150 and its LN insert were visualized in AC mode using JPK Nanowizard3 AFM. B) 
pEI7151 and its HN insert were visualized in AC mode using JPK Nanowizard3 AFM C) 160 
fmols of 601 DNA and 280 fmols of recombinant human histone octamer (H) were incubated in 20 
µL of high salt buffer for 30 min before dialysis. The final solution in 0.2 M NaCl, 10 mM Tris pH 
8.0, 1 mM EDTA and 1 mM DTT was added onto MICA poly-L-ornithine coated surface and 
imaged in AC mode. Images are representative of different field of view.  
 
In vitro nucleosome reconstitution assay using pEI7150 and pEI7151 inserts, LN and HN 
regions was performed and visualised. When low nucleosome forming regions were 
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incubated with histones and visualized with AFM, no major changes in DNA height or 
topology were observed (Figure 37). 
 
Figure 37 - LN region topology in the presence of histone octamers  
A) LN insert were visualized in AC mode using JPK Nanowizard3 AFM. B-C) LN insert in the 
presence of histone octamer was visualized in AC mode using JPK Nanowizard3 AFM. 160 fmols 
of pEI7150 insert (1.1 Kb) and 280 fmols of recombinant human histone octamer (H) were 
incubated in 20 µL of high salt buffer for 30 min before dialysis. The final solution in 0.2 M NaCl 
was loaded onto MICA poly-L-ornithine coated surface and imaged in AC mode. JPK image 
processing program: turquoise lines crossed DNA and compacted DNA. D) The height of the 
regions crossed by the line (turquoise in figure C) is reported. No major changes in DNA topology 
or height are observed. Images are representative of different field of view.  
 
On the other hand, when high nucleosome forming regions were incubated with histones 
under the same conditions, we could observe a significant change in DNA conformation, 
with an increase in DNA compaction and in the number of crosslinks intra- and inter-
strand (Figure 38 B-C).  Moreover, when we measured the height of the condensed 
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regions we could observe a 3 to 4 fold increase in those regions compared to non-
condensed DNA (Figure 38 D-I). DNA is known to be 2 nm in height, while nucleosomes 
form a cylinder 9 nm in diameter and 5 nm in height. According to literature, low force 
tapping mode measurements of DNA height have reported smaller dimensions than 2 nm, 
both in air (less then 0.7 nm) and in buffer (0.4 nm)(182). One possible explanation is that 
the treated substrate (MICA surface on which DNA is attached) can be the source of 
morphological changes seen in the DNA. According to our measurements DNA is 0.3-0.4 
nm high, while condensed regions are 0.7 to 0.8 nm high, thus we observed a 2 fold 
increase in high. We can conclude that pEI7150 insert is not forming nucleosomes, while 
pEI7151 insert has high affinity for nucleosome assembly. 
 
Figure 38 - HN region topology in the presence of histone octamers 
A) HN insert were visualized in AC mode using JPK Nanowizard3 AFM. B-C) HN insert in the 
presence of histone octamer was visualized in AC mode using JPK Nanowizard3 AFM. 160 fmols 
of pEI7151 insert (1.1 Kb) and 280 fmols of recombinant human histone octamer (H) were 
incubated in 20 µL of high salt buffer for 30 min before dialysis. The final solution in 0.2 M NaCl 
was loaded onto MICA poly-L-ornithine coated surface and imaged in AC mode. Compaction of 
DNA is observed.    E-F) Magnifications of HN insert in the presence of histone octamer. JPK 
image processing program: turquoise lines crossed DNA and compacted DNA. G-I) DNA 
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structures height was analysed with JPK image processing program (turquoise lines in Figure E-
F). In the right schemes the height of the regions crossed by the line is reported. Images are 
representative of different field of view.  
 
3.12 - NUCLEOSOME FORMATION ALTER DNA REPAIR PROTEIN RECRUITMENT 
UPON AID-INDUCED DAMAGE  
 
Once confirmed that plasmids with different ΔGs have different affinity for histones 
proteins, we analysed those plasmids in the IVR assay. Plasmids were prepared 
simultaneously at 4°C and topology was monitored in a gel mobility assay (Figure 39A).  
pEI7150 and pEI7151 are 5.1 kb long, while pGL4.31 is 6 kb long. Topology was 
conserved among different plasmids, independently from incubation with G-AID: 
supercoiled fraction was always over 90 % (Figure 39A). 
Subsequently, IVR was performed with increasing concentrations of FE, using as control 
the standard plasmid pGL4.31 (Figure 39B). During qPCR amplification of the 3 plasmids 
an identical DNA segment was amplified, flanking the HN or LN regions. Following AID 
damage, differences in the total repair activity in the FE were observed. Differences could 
be the result of differential AID deamination activity or differential DNA repair activity or a 
combination of the two.  
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Figure 39 - Plasmids with different affinities for nucleosome formation differentially 
repaired AID-induced lesion 
A) Gel mobility assay using different plasmids (produced simultaneously at 4°C). pGL4.31 is 6 
Kb, while pEI7150 (LN) and pEI7151 (HN) are 5.1 Kb. Supercoiled DNA (SC) migrated faster 
than nicked/open circular (N/Oc). SC fraction is more than 90 % and no topological changes are 
observed if G-AID is pre-incubated 30 min with the plasmids. B) 300 ng of each plasmid 
(pGL4.31, pEI7150 or pEI7151) were incubated 30 min with G-AID WT or mt and were processed 
by different amounts of FE (X-axis). Reaction was performed in the presence of bio-dC. 
Deaminated and repaired plasmids were isolated and quantified as pg as % of input (total amount 
of plasmids). Primers used for the qPCR analysis amplified the same region in the different 
plasmids. G-AID mt results were subtracted from G-AID WT results. Magnification of lower 
concentration shown in insert.  
 
Overall there was a decrease in the total repair activity when pEI7150 (LN) and pEI7151 
(HN) were used as substrate, as compared to pGL4.31. This was independent from the 
concentration of FE used. This indicated that FE was not a limiting factor in the lesion 
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resolution. As observed before (Figure 17B), when 20 to 50 µg of extract were used, an 
inhibition of global repair activity was registered before the linear profile appeared again. 
This phenomenon was visible with all the 3 substrates, indicating this was not related to 
the sequence context or to the formation of nucleosomes, but rather to the concentration 
of active DNA repair molecules. One possibility is that when molecules reached a defined 
concentration they can interact more easily among them, exerting activating or inhibitory 
functions, such as competition. If we consider the two peaks as distinct repair pathways 
activation, we observed in the presence of pEI7151 (HN) a more pronounced activation of 
the first pathway and a subdued activation of the second one, while with pEI7150 we 
observed exactly the opposite trend. We hypothesized that these profiles were the result 
of nucleosome interference with repair protein recruitment.  
To distinguish if the number of dU have an influence on nucleosomes or if chromatin is 
influencing repair activity, we performed two IVR experiments: 1) time-course of AID 
deamination reaction and 2) incubation of FE with UGI and aphidicolin inhibitors to 
distinguish single repair pathways involvement in AID lesion resolution (Figure 40). 
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Figure 40 - DNA sequence composition influences both G-AID deamination activity and 
IVR repair activity 
A) G-AID WT or mt were incubated with 300 ng of pEI7150 and pEI7151 and reactions were 
stopped at different timepoints before performing the repair phase of IVR, in the presence of 150 
µg of FE and bio-dC. pEI7150 allowed an higher deamination and repair reaction in particular 
after 60 min. B) Single repair pathway analysis, AID lesions were analysed when IVR was 
performed in the presence of pEI7150 or pEI7151. FE was incubated with bio-dC or with UGI 10 
min on ice before addition of bio-dC. White circle represents unknown pathways contribution (SP-
BER STM dependent and clMMR). C) Single repair pathways were calculated referring to AID 
deamination activity (shown in A) Maximum activity between the two plasmids in each repair 
pathway is set to to100. Light colours refer to pEI7150 (LN); dark colours refer to pEI7151 (HN). 
 
From the time-course analysis (Figure 40A), independently from the FE concentration 
used, we observed differences due to G-AID deamination reaction in the two substrates. 
Major differences were appreciable at 60 min, where in pEI7150 (LN) G-AID was 2-3 fold 
more active in IVR compared to pEI7151 (HN) (Figure 40A). Hence, it was possible that 
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pEI7150 was more easily targeted by G-AID protein, while pEI7151 was less deaminated 
and repaired.  
We then analysed different repair pathways recruitment at the lesion combining results 
from bio-dC or bio-dA incorporation with the use of UGI and aphidicolin (Figure 40B). 
From the preliminary results, it is clear that nucleosome formation potentially affected the 
repair pathways recruitment. pEI7150 (LN) is mostly repaired by SP-BER (UNG-
dependent), while pEI7151 (HN) is mostly repaired by LP-BER (UNG-dependent). When 
DNA is unlikely binding nucleosomes, supercoiled DNA is easily accessible for the fast 
component of BER (SP-BER), while when DNA is wrapped around nucleosomes it is 
preferentially repaired by the slow component of BER (LP-BER). Moreover, if repair 
pathways recruitment is calculated in relation to AID deamination activity (2.5 fold higher 
in pEI7150 after 60 min – Figure 40A) MMR is 4 fold reduced in pEI7151 compared to 
pEI7150 (Figure 40C). LP-BER and SP-BER differences are conserved. G-AID could 
have a role in sending signals to the repair pathways or could be directly involved in 
recruiting DNA repair proteins.  
 
3.13 - PROTEIN INTERFERING WITH AID CAN MODIFY ITS ACTIVITY AND 
INFLUENCE REPAIR PROTEIN RECRUITMENT  
 
Our lab recently discovered that AID has a novel function by influencing the downstream 
IVR activity (Willmann, Franchini, et al. under revision). The work showed that AID 
associates with the sliding clamp PCNA, which is a cofactor of numerous repair pathways, 
including MMR and LP-BER. This association can influence PCNA post-translational 
modifications at K164, a site known to influence DNA repair choice, error prone or error 
free (183,184). As a direct consequence of AID-PCNA interaction, PCNA K164 
modification can be altered, and hence AID can influence how dU lesions are processed. 
To verify the association and influence of AID on PCNA in the IVR, PCNA was incubated 
with G-AID before IVR reaction, and the overall deamination and repair is reduced (Figure 
41). This is possibly due to PCNA interfering with G-AID binding and activity. While if 
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PCNA is added to deaminated plasmid after AID-activity and before the extract repair 
reaction, overall repair could be enhanced (Figure 41). This is possibly due to AID 
recruiting PCNA directly to the lesion. PCNA addition to the FE post lesion generation did 
not change the IVR repair activity profile, possibly due to the large amount of PCNA in the 
FE.  
Moreover if G-AID protein is removed before the repair reaction is performed, a decrease 
in the overall repair activity is observed (data not shown). This suggests that AID functions 
are important not only in the IVR deamination reaction, but also in the subsequent repair 
reactions.  
 
 
Figure 41 - PCNA interfere with G-AID induced DNA resolution 
IVR assay was performed with 6 fold excess PCNA incubation with G-AID before and after 
deamination reaction or during repair reaction (with FE). pGL4.31 was used during the assay. 
Values of repaired and deaminated plasmids are expressed as pg as % of input. Error bars 
indicate SD (n=3). Statistical analysis (t-test) was performed on differences between A and C in 
Ramos and HelaS3. * p values are indicated in the figure. 
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CHAPTER 4 - DISCUSSION 
 
Genomes are under constant threat from chemical, physical, and biological agents that 
induce DNA damage. Proficient repair of those damages by multiple DNA repair pathways 
ensures the survival of the organism. On the other hand, DNA lesions are necessary for 
some physiological mechanisms, such as the formation of a healthy adaptive immune 
system and proper chromosome segregation during meiosis. DNA lesion resolution plays 
a key role in determining the distribution of mutation versus repair. Understanding how 
physiologically induced lesions are resolved provides insight into how the balance 
between homeostasis and evolution regulates survival.  
In the present study I investigated how a single type of lesion (uracil) is processed by 
different cellular systems, with a new biochemical assay named IVR. AID, the prototypical 
DNA deaminase and a physiological lesion generating protein, was used to introduce 
DNA lesions, and multiple repair pathways acting during the processing of dU lesions 
were characterised. In particular, with the IVR, we demonstrated that different cell extracts 
respond to AID-damage in a specific way and that lesion processing is influenced by 
different molecular pathways, such as single repair protein activity, transcription, 
chromatin remodelling and protein association with AID. 
 
4.1 - ESTABLISHMENT OF AN IN VITRO APPROACH TO STUDY DNA LESION 
RESOLUTION 
 
We established a new biochemical assay, IVR, which recapitulates the activity of AID in 
combination with the subsequent resolution by an extract. G-AID was targeted to SC DNA 
and the induced-damage was repaired by addition of FE or cellular extracts. This method 
allows the direct quantification of G-AID activity and extract specific repair activity. 
To perform IVR assay, we ensured to quantify exclusively resolution of DNA damage 
generated by AID and not via other mechanisms. Each single component of the assay 
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was evaluated for unspecific DNA damage induction: AID, the substrate DNA, and the 
source of DNA repair proteins.  
The principal difficulty in performing biochemical studies about AID and repair kinetics is 
that the protein is sticky and aggregates quickly after purification, thus possibly binding 
nucleases. A protocol was optimized for G-AID fusion protein production from E. coli. 
Other labs reported the advantages of AID protein purification from a bacterial system, in 
that the purified proteins do not contain RNA and are active (185), unlike the GST-AID 
purified from insect cells, which requires ribonuclease activity to deaminate a DNA 
substrate (116). We demonstrated that G-AID proteins produced from E. coli are active 
and endonucleases-free (Figure 12 and 13). Catalytic activity of AID is a requirement for 
the initiation of the IVR assay (Figure 16), while absence of nucleases ensures to quantify 
repair of DNA lesion exclusively due to AID.  
We then controlled the DNA substrate of IVR, by maximizing SC fraction production (160) 
to ensure access of ssDNA to AID. Moreover, we demonstrated that the plasmid topology 
was not affected by AID deamination reaction. 
Finally, in the IVR assay we controlled the source of DNA repair proteins. Xenopus laevis 
egg extract was used as model because it is cost-effective, easy to prepare, and more 
importantly it has been used for DNA repair studies since 1987 (186); indeed, in the past 
several experiments have been performed injecting damaged DNA into FE and monitoring 
DNA damage response or cell cycle progression (163,187). The major disadvantage of 
the system is the absence of transcription during early embryonic division (176), which 
could affect DNA repair.  
Studying DNA repair in mammalian extracts is more complex, because lysate were shown 
to be less efficient in repair compared to Xenopus egg extract. Moreover, it is more 
difficult to obtain active DNA repair proteins which are not contaminated by unspecific 
nucleases. The background activity from contaminants was removed during calculations, 
because each experiment was performed in parallel using a G-AID catalytic mutant as 
control. Repair activity detected using a catalytic dead protein as damaging agent (due to 
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extracts unspecific repair or to G-AID co-purified contaminates), was excluded from our 
calculations. 
Selection of different human cell lines was aimed to investigate microenvironment 
contribution to damage resolution. In particular, we started our analysis comparing B cell 
and non-B cell lines. By checking how different cell lines process DNA lesions, we can 
analyse different networks required for maintaining DNA stability. We used B cell lines, 
since AID is physiologically expressed in those cells and thus quantification of repair 
pathways activation can be a direct reflection of what is occurring in vivo during Ig locus 
diversification.  
With a human cell based system the field of research can be expanded to primary cancer 
cells to have more clinical relevance. The study of DNA repair mechanisms activation in 
different cancer cells or at different stages of cancer progression can provide important 
insight into oncology. Cancer cells are exposed to high levels of replication stress and 
DNA damage. Understanding specific DNA repair pathways activation enables the use of 
specific DNA repair inhibitors to trigger apoptosis and cell death. Indeed, several inhibitors 
of DNA repair have been developed and clinical trials are ongoing (188); with the IVR 
assay it will be possible to calculate major repair pathways involved in cancer cells and 
address specific drug targeting. 
The beauty of the IVR system lies in its versatility; once all the aspects of AID lesion 
generation have been controlled, I used the IVR assay to perform different kind of 
analysis: 
- extracts repair protein compositions and activation, through the use of repair protein 
inhibitors or through the preparation of extracts from synchronized cells; 
- chromatin interaction with DNA repair proteins using a modified substrate (nucleosomes 
and chromatin retaining plasmids versus not nucleosome assembling plasmids); 
- analysis of AID protein activity through the association with other proteins (i.e. PCNA). 
Further analysis can be performed using depleted extracts. For example, one can use 
extracts derived from cells genetically ablated from MMR or BER proteins (Ilaria 
Spadafora and Elisabetta Incorvaia, unpublished observation) or extracts depleted of 
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nucleosomes. Zierhut and colleagues developed a method to remove histones H3 and H4 
from Xenopus egg extracts, such as they are incapable of forming nucleosomes (189). 
This extract could be used to better investigate how nucleosomes influence AID damage 
and subsequent DNA repair.  
Also DNA substrate used during IVR can be modified, for example a methylated DNA can 
be used to further investigate AID function in DNA demethylation (143).  Mutated DNA can 
be used to mimic DNA of cancer cells and repair pathways activated can be investigated. 
 
4.2 - DIFFERENT CELL LINES ACTIVATE DIFFERENT REPAIR SYSTEMS UPON AID-
INDUCED DNA LESION 
 
To determine if the AID-induced lesions are processed in a similar manner in different 
biological context, we perform the IVR resolution phase using extracts from different cell 
lines.  
All cellular extracts are capable to repair AID-induced damage, but to different extent, 
such that maximum repair activity is different among the extracts used. All cellular extracts 
display maximum repair activity at 20 µg, while FE is fully active only at >150 µg. As 
packing of DNA is a primary determinant of slow repair in chromatin and knowing that FE 
is able to support chromatin assembly in vitro (190), I hypothesize that chromatin 
assembly is involved in slowing down repair.  
Besides playing a role in maximum repair activity, concentration of extracts, hence 
concentration of repair protein, plays an important role in the single repair pathways 
activation: some repair pathways are more active at low concentration of extracts, while 
others are predominantly active at higher concentrations (Figure 22 and 23). This trend is 
influenced by the cellular microenvironment: at low concentrations in B-cells and in FE, 
SP-BER is more active, while in non-B cells clMMR is the predominant pathway activated. 
Interestingly, analysing DNA repair proteins content in each extract we derived that 1) 
EXO1, a key protein of MMR, is more abundant in non-B cell extracts, 2) B cell are 
enriched in UNG and MBD4 glycosylases, and 3) FE is expressing high amounts of UNG 
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(Figure 21). This quantification correlate with the first specific response activated by DNA 
repair machinery upon AID damage (Figure 22): at lower concentrations proteins more 
abundant are the first to reach the lesion and actively perform repair.  
Besides concentration, the time needed for each repair protein to reach the lesion site 
may play a role in specific pathways activation. Glycosylases can perform both lesion 
recognition and excision, while MutS has no cleavage activity towards DNA and needs to 
be associated with both ATP and a mismatch to recruit MutL and activate nucleases. 
Moreover, SP-BER does not require DNA re-synthesis and was reconstituted in vitro 
using only 4 purified enzymes (191), while 11 active proteins are required to carry out 
MMR in E. coli and in vitro (192). I hypothesise, that besides displaying easier lesion 
recognition and a higher turnover, SP-BER components may achieve the concentration 
needed to perform repair faster than MMR, which require more proteins to reach the 
active conformations.  
This is what we observe in B cells and in FE, while in non-B cells we observe the opposite 
trend, with more clMMR activation al lower concentrations. Probably, due to their 
abundance, MMR protein can recognize and bind first the lesion, which is then less 
accessible for BER.  
From the maximum repair activity we quantified single repair pathways active in repairing 
AID lesion, and we observed significant differences between different cell lines. LP-BER is 
hardly detectable in non-B cell lines, while in Ramos it is the predominant functional 
pathway. FE displays a profile of repair pathway activation very similar to Ramos. Both 
systems express endogenous AID. AID may be linked to a specific microenvironment and 
to specific repair pathways abundance of deficiency in the cells or systems.  Ramos and 
BL2 displayed some similarities (e.g in LP-BER activation) and some differences (e.g. in 
MMR activation); it would then be interesting to stimulate endogenous AID expression in 
BL2 cell line and analyse possible variations in single repair pathways activation. 
Another observation derived from this quantification is that ncMMR is activated both in B-
cell lines and in non-B cell lines. Our results confirm recent findings that error-prone 
ncMMR can occur also outside the immune system (53). Biological relevance of error-
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prone repair has been extensively discussed for healthy immune system development, 
however I was expecting non-B cells to activate only error-free repair, as mutation 
introduction can have detrimental effects. Non-B cell lines used in this project are 
immortalized. p53 and p21, both able to interact with PCNA, were shown to play an 
important role in down-regulating the error-prone TLS polymerases recruitment in 
mammalian cells (193). In cancer cells, p53 or p21 inactivation can lead to TLS 
deregulation and to mutagenic bypass of DNA lesions. It would then be interesting to look 
at the expression of TLS polymerases in the cells used in the IVR. Furthermore, one can 
silence p53 in cellular extracts and evaluate how molecules important for tumorigenesis 
can influence DNA repair pathways activation. At the moment, I hypothesize that ncMMR 
is finely regulated and that a certain balance between introduction of mutation and 
efficient repair is needed for cell survival.  
Our assay is the first to demonstrate a quantifiable cell specific response to AID-induced 
damage. Cellular microenvironments play a role in determining which pathway is 
preferentially activated and when.  
 
4.3 - DNA GLYCOSYLASES DISPLAYED DIFFERENT ACTIVATION KINETICS IN 
DIFFERENT CELL LINES 
 
To better investigate single repair pathway role in AID lesion resolution, kinetics of DNA 
glycosylases involved in uracil recognition and SP-BER initiation were analysed. In all the 
extracts analysed, UNG activity was dominant over the other uracil glycosylases with STM 
playing only a minor role in SP-BER initiation (less than 10 % - Figure 29A). This is in 
agreement with previous observations, as UNG showed the highest turnover compared to 
other uracil recognising glycosylases (194) and UNG deficiency cannot be fully 
compensated by other uracil recognising glycosylases (130).  
Contrary to cell extracts, UNG proteins in FE have a low turnover. Moreover, FE is the 
extract displaying higher SMUG1, TDG, and MBD4 activities (34 % - Figure 24A). 
Previously, SMUG1 was shown do display a very low turnover compared to UNG, and 
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distinct roles were proposed for the two proteins in BER: slow SMUG1 enzyme was 
proposed to repair deaminated cytosine in non-replicating chromatin, while highly 
coordinated repair by UNG was proposed for replicating DNA (134). We cannot analyse 
replication interference, because we inhibit replicative polymerases with aphidicolin, but 
we observed, at least in FE, a role for both UNG and STM glycosylases. Low UNG 
turnover and relevant STM activity may be indicative of coordination between DNA 
glycosylases to activate BER. FE’s low UNG turnover may be directly related to high 
amount of extract needed to perform maximum repair activity in IVR assay (150 µg were 
needed to reach maximum activity), as 68 % of uracil repair is initiated by DNA 
glycosylases in FE. It is known that transcribed DNA is repaired faster than non-
transcribed DNA. We confirmed that Xenopus embryonic genome is transcriptionally silent 
and this may be related to nucleosome interference with AID deamination and repair, 
resulting in slow repair pathways activation (low UNG turnover and lots of active 
molecules necessary to achieve maximum repair in FE) and in a major role for SMUG1. 
Glycosylases activity calculated on small oligonucleotides was compared to SP-BER on 
longer DNA molecules, accessible by other repair proteins, such as MMR and LP-BER 
components. A compensatory mechanism, derived from UNG inhibition (used in IVR) is 
actuated by STM glycosylases. This compensation was not observed in FE, probably 
because basal levels of STM glycosylases are already enough to support UNG 
inactivation. The compensatory mechanism is likely to be stimulated by other repair 
pathways, as it is not occurring in small oligonucleotides.  
 
4.4 - DNA SEQUENCE SPECIFICITY INFLUENCE AID-INDUCE LESION RESOLUTION  
 
I also analysed if other mechanisms could influence deamination and repair activity, in 
particular we evaluated chromatin, since chromatin compaction can impede access of 
repair proteins to the damaged sites (178). We decided to change a single parameter in 
IVR assay, inserting in the SC plasmid sequences with altered affinity for nucleosomes. 
Sequences with low or high affinity for nucleosome formation (called LN and HN, 
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respectively) were validated via Atomic Force Microscopy (Figures 37 and 38) and were 
subsequently tested in the IVR assay with FE. We observed significant differences both in 
AID deamination activity and in single repair pathways activation upon AID damage. In 
particular, G-AID seems to have higher affinity for low nucleosome forming sequences, 
while the DNA repair pathway more affected by this substrate change is BER.  Despite 
low nucleosome regions contains only 26 % of GC bases, G-AID induced more dC 
deaminations in plasmids with LN region, compared to HN sequence (54 % GC 
composition). It is known that AID has a preferential target site (120,129), but other DNA 
features seem to influence G-AID targeting. In the presence of non-nucleosome forming 
DNA the majority of uracil repair is performed by SP-BER and MMR pathways, while in 
the presence of nucleosome-forming DNA, LP-BER is the major repair pathway activated.  
One study demonstrated that DNA glycosylases and AP endonuclease are also active on 
DNA substrates bound by nucleosomes, but their activity was decreased by 90 % 
compared to naked DNA (195). We didn’t observe a global reduction of DNA repair when 
HN regions were inserted in the SC plasmid, but we reported a switch from one repair 
pathway to another. 1 Kb DNA sequence alteration was enough to trigger different DNA 
repair pathways activation. This is possibly occurring through the interplay of different 
mechanisms, including transcription, proteins with nucleosome disassembly activity and 
additional factor that allow DNA repair to proceed in the specific context.  
Perturbation of nucleosome assembly and nucleosome dynamics in vivo will lead to 
aberrant gene expression and genome instability, it this then important to understand how 
DNA repair machinery is coordinated with a variety of DNA dependent processes. 
We recently discovered that AID has a second function: it can influence PCNA post-
translational modification, and thus it can select preferential repair pathway activation. 
Subsequent to AID lesion generation, PCNA interact with specific proteins allowing 
access to the damaged locus. This process requires the coordination and interaction 
between different proteins and with histones. In the IVR assay chromatin remodelling is 
occurring after AID damage, but if we consider AID second function in regulating PCNA, 
nucleosome formation upon extract addition to the deaminated plasmids may induce the 
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displacement of AID from the lesion site. This phenomenon can contribute to a differential 
regulation of PCNA and different repair pathways are activated. In this scenario DNA with 
nucleosome favourable base-stacking induce LP-BER activation, while SP-BER and MMR 
are the preferential pathways activated in the presence of non-nucleosome stacked DNA; 
probably because less regulation is needed in this context or repair proteins are already at 
the damaged site.  
Based on these observations we derived multiple-models (Figure 42).  
 
 
 
 
 
Figure 42 – Multiple-model of how cellular microenvironment influence AID-induced DNA 
damage repair 
A) FE extract perform the repair of DNA harbouring HN forming sequences. Nucleosomes (red 
bubbles wrapped by blue DNA), PCNA and AID collaborate to trigger LP-BER activation B) FE 
extract perform the repair of DNA harbouring LN forming sequences. SP-BER is the major 
pathway recruited. C) In B cells extracts transcription and PCNA trigger LP-BER activation upon 
AID-induced damage. D) In non-B cells extracts specific cellular environment leads to SP-BER 
and MMR activation.  
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Cellular context influences which repair pathway is activated upon AID damage, in 
particular DNA dependent processes, such as chromatin and transcription, have a role in 
determining which repair pathway is preferentially recruited. 
Depending on the DNA substrate, G-AID will insert a certain number uracil lesions. Once 
FE is added to the assay to induce repair, (again depending on the DNA substrate) it will 
either form nucleosomes or not. In the first case, other cellular proteins, chromatin-related, 
are necessary to disassemble chromatin and allow DNA repair machinery access to 
damaged sites. AID itself has a role in influencing other proteins, such as PCNA, known to 
interact with different repair proteins. Interaction and coordination between different 
processes lead to the recruitment of a specific repair pathway: LP-BER (Figure 42A). If 
the DNA substrate has a different sequence composition, with low nucleosome potential 
formation, more uracil lesions will be introduced by G-AID and FE addition will not lead to 
nucleosomes formation. In this scenario DNA is not protected by nucleosomes and major 
repair pathways recruited are SP-BER and MMR (Figure 42B).  
In B cell extracts histones are present, thus it will be interesting to see how a modified 
DNA can influence nucleosome formation and DNA repair. We know that those cells have 
a short cell cycle, high transcriptional activity and specific cellular environment, which 
influence how a lesion is processed. The specific environment and AID interacting with 
PCNA may collaborate to recruit LP-BER (Figure 42C). Identification and separation of 
SP-BER, LP-BER, and MMR pathways involvement in uracil repair is a direct reflection of 
AID-lesion processing in vivo during Ig locus diversification in B cells. Finally in non-B 
cells another specific environment, characterized by low transcription and low histones, 
may be related to multiple pathways recruitment at the lesion, indeed SP-BER and MMR 
are the preferential pathways activated in non-B cells (Figure 42D).   
 
 
 
 
 
DISCUSSION 
	   	  	  	   121 
4.5 – FUTURE PLANS 
 
4.5.1 - IVR future plans 
I was able to demonstrate that different cell lines activate different repair mechanisms 
upon AID damage and that cellular context is regulating this process. 
♦ I will complete the analysis of chromatin interference with DNA repair in B cells and 
non-B cells, as we did in FE.  
♦ To assess if endogenous AID may have a role in influencing protein recruitment 
(independently from its catalytic activity) a comparative IVR analysis will be performed 
using extracts derived from activated or not activated BL2 cell lines.  
♦ With further analysis, the physiological process of DNA demethylation can be directly 
investigated, using a methylated substrate in IVR.  
♦ Other physiological or tumorigenic processes will be dissected studying repair 
pathways recruitment performed by primary cell lines.  
 
4.5.1 - analysis of G-AID efficiency and G-AID function in DNA repair recruitment  
I would like to better characterize G-AID deamination activity and G-AID function in 
recruiting DNA repair proteins: 
♦ A more detailed quantitative analysis can be performed knowing exactly the efficiency 
of G-AID deamination. With AFM, I can quantify exactly the number of cytosines 
deaminated and repaired, and better quantify G-AID efficiency. I will directly visualise 
plasmids after incubation with G-AID with AFM. After IVR resolution the substrate 
plasmid will have biotins incorporated, which can be visualised using streptavidin 
proteins.  
♦ At the same time the use of a plasmid containing a single uracil in IVR, in the absence 
or presence of AID, can give us more information about AID function in recruiting 
specific repair proteins.  
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♦ This function will be further investigated analysing if each single cell line can induce 
specific AID post-translational modifications, possibly involved in specific repair protein 
recruitment.  
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